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Abstract 
The present study investigated the genotoxic potential of the marine 
biotoxins okadaic acid (OA) and azaspiracids (AZAs). Harmful algae blooms 
(HABs) are an increasing global problem with implications for the ecosystem, 
economy and human health. Most data available on human intoxication are 
based on acute toxicity. To date, limited data has been published on possible 
long term effects, carcinogenicity and genotoxicity. To investigate 
genotoxicity in the present study, DNA fragmentation was detected using the 
COMET assay. In contrast to most other available studies, two further 
endpoints were included. The Trypan Blue Exclusion assay was used to 
provide information on possible cytotoxicity and assess the right 
concentration range. Flow cytometer analysis was included to detect the 
possible involvement of apoptotic processes. In house background data for 
all endpoints were established using positive controls. Three different cell 
lines, Jurkat T cells, CaCo-2 cells and HepG-2 cells, representing the main 
target organs, were exposed to OA and AZA1-3 at different concentrations 
and exposure times. Data obtained from the COMET assay showed an 
increase in DNA fragmentation for all phycotoxins, indicating a modest 
genotoxic effect. However, the data obtained from the Trypan Blue Exclusion 
assay showed a clear reduction in cell viability and cell number, indicating 
the involvement of cytotoxic and/or apoptotic processes. This is supported by 
data obtained by flow cytometer analysis. All phycotoxins investigated 
showed signs of early/late apoptosis. Therefore, the combined observations 
made in the present study indicate that OA and AZA1-3 are not genotoxic 
per se. Apoptotic processes appear to make a major contribution to the 
observed DNA fragmentation. The information obtained in this study stresses 
the importance of inclusion of additional endpoints and appropriate positive 
controls in genotoxicity studies. Furthermore, these data can assist in future 
considerations on risk assessment, especially regarding repeated exposure 
and exposure at sub-clinical doses.  
Chapter 1: General Introduction 
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Chapter 1: General Introduction 
Biotoxins 
Background 
Approximately 4000 phytoplankton species have been identified to date and 
about 300 of them can occur in high enough numbers to form so called 
harmful algae blooms (HABs). HABs is a broad term and includes visible 
(surface) blooms so called red tides and non-visible blooms with too small a 
population to discolour the water or which occur in deeper water levels [1]. 
Over the last few decades the frequency and intensity of HABs has 
increased as well as the geographical regions in which they have been 
reported [1-4]. The exact reasons for HABs remain unknown but suggestions 
have been made towards both natural mechanisms and human influence. 
Natural changes in the environment, for example increased temperature, 
light penetration and nutrient availability have been proposed as possible 
contributing factors for rapid population growths. Climate change, 
eutrophication, commercial shipping and the increased usage of coastal 
waters for aquaculture could also be held account for it, as well as a general 
increase in awareness and monitoring programs [5-11]. Of the species 
involved in HABs, approximately 60-80 are potential toxin producers [1, 12]. 
Some produce toxins at population densities as low as 100 cells/l, others at 
densities at 1 x 106 cells/l or higher. Toxin production has been suggested as 
a mechanism to improve the ability of species to compete for space, avoid 
predation and overgrowth; however the exact reasons remain unclear [8]. 
Both toxic and non-toxic blooms can have negative impacts on the 
environment. The increase in biomass can lead to oxygen depletion, reduced 
light penetration and disruption of food web dynamics [6, 13]. Phycotoxins 
can have a direct impact on the marine fauna causing mortalities in fish, 
birds and marine mammals [6, 14, 15]. Plankton species release phycotoxins 
into the water but also serve as a food source for filter feeding shellfish and 
the larvae of some crustaceans and finfish allowing accumulation throughout 
the food web. Mussels (Mytilidae), oysters (Ostreidae), clams (Veneridae) 
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and scallops (Pechinidae) are the main bivalve species affected and are able 
to accumulate phycotoxins in their digestive glands up to levels that pose 
health implications to human consumers [1, 2, 5]. Acute intoxication has 
been reported with a variety of gastrointestinal and neurological symptoms 
but little is known about the impact of chronic exposure on humans [8]. 
Phycotoxins are a diverse group of chemicals with different structures, 
physical properties, mechanisms of action, potencies and toxic effects [16]. 
Historically they were organised in groups due to their symptoms caused in 
humans, however recently they have been re-grouped based on their 
chemical structure (Table 1.1.) [8, 9, 17].  
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Table 1.1. Overview of the biotoxin groups organised historically by their toxic syndrome/clinical symptoms and by their chemical structure. 
Acute symptoms in humans and cellular targets are listed, as far as they have been reported in the literature [9, 16, 18, 19]. 
Toxin group   Reference compound/ Acute symptoms  Cellular target 
Chemical structure Historical classification analogues in humans   
 
Azaspiracid 
 
Azaspiracid Shellfish Poisoning (AZP) 
 
AZA1 
 
Gastrointestinal 
 
Unknown 
  
 
≥ 20 analogues (Neurological)   
 
Brevetoxin 
 
Neurotoxic Shellfish Poisoning (NSP)  
 
Gastrointestinal 
 
α-subunit of voltage 
  
  
Neurological sensitive Na-channels 
 
Cyclic imines  
 
Gymnodimine, Spirolide 
 
None reported  Muscle/neuronal types 
  
 
Pinnatoxins 
 
 of nicotine acetyl- 
  
 
Prorocentrolide 
 
 choline receptors 
  
 
Spirocentrimine 
 
  
 
Domoic acid 
 
Amnesic Shellfish Poisoning 
 
Domoic acid 
 
Gastrointestinal 
 
Kainate receptors 
  
  
Neurological   
 
Okadaic acid 
 
Diarrhetic Shellfish Poisoning (DSP) 
 
Okadaic acid 
 
Gastrointestinal 
 
Proteinphosphatase 1 
  
 
Dynophysistoxins 
 
and 2A 
  
 
≤ 10 analogues 
 
  
 
Pectenotoxin 
 
Diarrhetic Shellfish Poisoning (DSP) 
 
Pectenotoxin-2 
 
None reported  Actin 
  
 
≥ 13 analogues 
 
  
 
Saxitoxin 
 
Paralytic Shellfish Poisoning (PSP) 
 
Saxitoxin 
 
Respiratory paralysis 
 
Block voltage-gated 
  
 
≥ 30 analogues Death Na-channels (site 1) 
 
Yessotoxin 
 
Diarrhetic Shellfish Poisoning (DSP) 
 
Yessotoxin 
 
None reported 
 
Phosphodiesterase 
    ≥ 36 analogues   isoenzymes 
Chapter 1: General Introduction 
5 
 
Okadaic acid 
Okadaic acid (OA) and its analogues dynophysistoxins (DTX) are the most 
common phycotoxins involved in human intoxication and are the cause of 
Diarrhoeic Shellfish Poisoning (DSP) [20]. The earliest reports on DSP date 
back to 1961 in the Netherlands. The first confirmed incident of DSP 
however was in Japan in the late 70s [19]. Since then, thousands of cases of 
human poisoning have been reported worldwide, including Asia, Canada, 
United States, New Zealand and Europe (Figure 1.1.) [1, 22]. The areas 
most affected by OA seem to be Europe and Japan [23]. 
 
 
Figure 1.1. Worldwide occurrences of Diarrhoeic Shellfish Poisoning (DSP) 
are marked in red [6]. 
 
OA is a heat stable polyether fatty acid and is produced by dinoflagellates of 
the genus Dynophysis sp. and Prorocentrum sp.. Together with its 
analogues, DTX1-3 it forms the OA-toxin group. They differ in the position 
and number of methyl groups (Figure 1.2.), thereby DTX3 is a collective of 
the acylated forms of OA, DTX1 and DTX2 [24]. The acylated forms are quite 
unstable and have been suggested to be metabolic products as they have 
only been detected in shellfish and not in the toxin producing dinoflagellates 
Chapter 1: General Introduction 
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[25, 26].  The toxic equivalent factor1 (TEFs) for OA and DTX1 is 1, for DTX2 
0.6. The values for DTX3 are based on its unesterified equivalents [21]. 
 
 
 
R1 R2 R3 R4 
OA CH3 H H H 
DTX1 CH3 CH3 H H 
DTX2 H H CH3 H 
DTX3 CH3/H CH3/H CH3/H 
Fatty 
acid 
 
Figure 1.2. Chemical structure of Okadaic acid and its analogues. 
 
Due to their lipophilic properties OA-toxins are able to accumulate in the 
hepatopancreas (digestive gland) of various species of filter-feeding shellfish 
[28]. The most common species are bivalve molluscs, consumption of these 
posing a risk to human consumers. Acute symptoms of DSP include 
diarrhoea, nausea, vomiting and abdominal pain. Symptoms occur within a 
few minutes to hours after consumption and a full recovery of the clinical 
symptoms normally occurs within a few days [17, 23, 29]. No lethality has 
been reported with the severity of the effects depending on the amount of 
toxin ingested [8, 23]. The main acute effects of OA in mice and rats, under 
laboratory conditions, are intestinal injury and lethality, oral administration 
                                                          
1 The TEF is defined by the relative toxicity of an individual congener to either the most 
studied congener of the group, or if sufficient data are available, the most toxic compound. 
The latter is thereby assigned a value of 1 [27].  
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being 2-10 times less toxic than intraperitoneal (i.p.) administration [21, 30]. 
Administration by gavage2 showed OA to be well absorbed from the 
gastrointestinal (GI) tract and a distribution among all internal organs within a 
very short time period. Intestinal content, urine, intestinal tissue, lung, liver, 
stomach, kidney and blood all contained OA, in descending order. 24 hours 
after administration the tissue and contents of the GI tract still showed high 
amounts of OA, indicating slow elimination. OA was further present in the 
liver and bile which together with the wide distribution throughout all organs 
indicates enterohepatic circulation to have taken place [23, 32]. A more 
recent study by Ito et al. [30] confirmed the distribution pattern, finding OA in 
lung, liver, small and large intestine, heart and kidney after oral 
administration. Additionally, the authors detected lung injuries and oedema in 
and erosion of intestinal villi as well as hypersecretion after single dosing of 
up to 250 µg OA per kg body weight. In contrast to rats receiving OA 
intragastrically and human cases, no diarrhoea could be seen in mice as 
fluids and eroded tissues were re-absorbed efficiently [33]. After 
administration, OA could be detected for another two weeks in liver and 
blood and for another four weeks in excretions from the intestine. A study by 
Tripuraneni et al. [35] failed to show OA as secretagogues yet reduction in 
resistance across cell monolayers could be detected. The authors concluded 
OA to disrupt the barrier function and increase paracellular permeability 
rather than directly stimulate secretion. In vitro studies have identified OA to 
be a potent inhibitor of serine/threonine phosphatase PP1 and PP2A in 
mammalian cells [35, 36]. The resulting hyperphosphorylation of proteins 
leads to a change in many cellular processes, including proliferation, 
differentiation and apoptosis [37-40]. Morphological and cytoskeletal 
changes have frequently been reported, including cell-cell and cell-surface 
detachment, cell rounding and effects on F-actin organisation and cytokeratin 
network [41-45]. A variety of studies have looked into the genotoxic potential 
                                                          
2 Gavage is a method by which a nutritional substance is directly supplied into the stomach of an 
animal by using a small plastic tube [31]. 
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of OA. No mutagenic effect in the Ames test was detected, with or without 
metabolic activation but experiments with Chinese hamster lung (CHL) cells 
showed OA to induce a strong genotoxic effect without metabolic activation 
[46]. A significant increase in sister-chromatid exchange (SCEs) and mitotic 
cells, characterized by chromosome condensation could be identified in 
human lymphoblastoid cells and Chinese hamster ovary (CHO) cells. OA 
furthermore induced chromosome fragmentation in human lymphoblastoid 
cells and fragmented nuclei in CHO cells [47]. Using a 32P-postlabelling 
method OA was found to induce a dose-dependent DNA adduct formation in 
BHK21 C13 fibroblasts and HESV keratinocytes at a non-cytotoxic 
concentration range. Both cell lines showed the highest effect in the middle 
range of the concentrations used, HESV cells being overall more sensitive to 
OA. The authors suggested differences in the cell cycle, the accessibility of 
OA to the cell lines and possible biotransformation potential to be 
responsible for the earlier DNA adduct formation in HESV cells. Based on 
the DNA adduct formation in both cell lines the authors concluded OA to 
have a direct effect on the DNA [48]. In contrast, no direct effect on the DNA 
could be identified in other studies using CHO-K1 cells and CaCo-2 cells [49, 
50]. The micronucleus (MN) assay in combination with fluorescence in situ 
hybridisation (FISH) showed OA to significantly induce MN at non-cytotoxic 
concentrations in CHO-K1 cells. The detected MN were centromere-positive, 
hence the authors suggested OA to be aneugenic rather than directly 
genotoxic [49]. OA also induced mononucleated and/or binucleated CaCo-2 
cells with centromere-positive MN, in the absence of cytotoxicity. Again, the 
loss of whole chromosomes suggests an aneugenic potential of OA [38, 50]. 
Further studies using the mammalian cell forward mutation test and in vitro 
unscheduled DNA synthesis (UDS) in rat hepatocytes and the MN assay in 
human lymphocytes confirmed the lack of primary/direct DNA damage. The 
authors detected a change in chromosome number (aneuploidy) which they 
suggested contributed to the carcinogenic effect of OA [38, 51]. A study on 
colon epithelial cells of mice in vivo was inconclusive whether or not OA has 
a direct genotoxic or an aneugenic potential [38]. Other studies have linked 
apoptotic/necrotic processes [43, 52-54], oxidative damage and the 
Chapter 1: General Introduction 
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possibility of metabolic activity [37, 55, 56] to OA toxicity. Souid-Mensi [28] 
proposed that the effect of OA might be cell line dependent. A 2-stage 
carcinogenesis experiment with a single application of  7,12-
dimethylbenz[a]anthracene (DMBA) followed by repeated application (twice a 
week) of OA to mouse skin prompted tumour development in 93% of the 
animals after 16 weeks. After 30 weeks an average of 2.6 tumours per 
mouse were detectable, hence the authors suggested OA to be a potent 
tumour promoter [57]. Further studies identified OA to also induce tumour 
promotion in rat glandular stomach after initiation with N-methyl-N´-nitro-N-
nitrosoguanidine (MNNG) and to prompt tumour necrosis factor α (TNF-α) 
gene expression in mouse skin [58, 59]. No additive or synergistic effect 
could be detected after simultaneous application of OA and teleocidin, a 12-
O-tetradecanoylphorbol-13 acetate (TPA) type tumor promoter [59, 60]. 
Together with the understanding that the inhibition of PP1 and PP2A alters 
gene expression, data suggests that OA has the potential to act as a non-
TPA-type tumour promoter [59, 61, 62]. However, data on long term effects 
are limited. Most information is based on acute toxicity and therefore no 
tolerable daily intake (TDI) can be established. For this reason the European 
Food Safety Authority (EFSA) panel on Contaminants in the Food chain 
decided on an acute reference dose3 (ARfD) of 0.3 µg OA equivalents per kg 
body weight [23]. Shellfish meant for human consumption is controlled by the 
Regulation (EC) No 853/2004 and the maximum amount of OA equivalents 
allowed in shellfish meat has been limited to 160 µg per kg. Due to the lack 
of long term data, concern has been expressed recently about potential 
effects of OA below the current regulation limit [37, 64]. 
 
 
                                                          
3 ARfD is an estimate of a substance in food or drinking water that can be ingested over a 
short time period, such as one meal or over one day, without an appreciable health risk to 
the consumer. The ARfD is thereby expressed on a body weight base [63]. 
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Azaspiracid 
The azaspiracid group (AZA) is the most recently discovered group of 
biotoxins and is the cause of azaspiracid shellfish poisoning (AZP). It was 
first detected in 1995 by an outbreak of human illness in the Netherlands 
after consumption of mussels from Killary Harbour, Ireland. The symptoms 
associated with the outbreak were similar to DSP; however levels of DSP 
toxins were below the regulatory limit [65, 66]. The toxin was later identified 
as a novel marine toxin and named azaspiracid. Since its first discovery, 
AZAs have been identified in numerous outbreaks around the world, 
including northern Europe, Spain, France and recently Japan, Morocco, 
South America, eastern Canada and the United States (Figure 1.3.) [67-71]. 
In contrast to other biotoxins, blooms have also been detected during the 
winter months [66, 72]. 
 
 
Figure 1.3. Worldwide occurrences of Azaspiracid Shellfish Poisoning (AZP) 
are marked in red [67-71, 73].  
 
AZAs are primarily produced by dinoflagellates of the genus Azadinium 
spinosum [74]. Azadinium comprises of six species, three of which have 
demonstrated toxin production to date. Recently, AZAs production has also 
been reported in the related dinoflagellate Amphidoma languida [73]. AZAs 
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are nitrogen-containing polyether toxins, their heterocyclic amine or aza 
group, unique tri-spiro-ring assembly and aliphatic carboxylic acid group are 
name giving. AZA1 was the first one to be identified and since then more 
than twenty further analogues have been discovered. AZA1-3 only differ in 
the number of methyl groups (Figure 1.4.). Most of these analogues are 
believed to be biotransformation products in shellfish and only AZA1 and 
AZA2 are said to be directly produced in Azadinium spinosum [73, 75-78]. 
AZA1 is heat stable (up to 100°C), colourless and at physiological pH 
electrically neutral, but contains both a negative and positive charge 
(zwitterion), AZA3 appears to be the most easily acid degradable of the 
analogues [76, 79]. Based on the limited toxicity data available TEFs have 
been established relative to AZA1; TEFs are AZA1 = 1, AZA2 = 1.8 and 
AZA3 = 1.4. AZA4 and AZA5, hydroxyl analogues of AZA3 are less toxic with 
TEFs of 0.4 (AZA4) and 0.2 (AZA5) [79]. 
 
 
 
R1 R2 R3 R4 
AZA1 H H CH3 H 
AZA2 H CH3 H H 
AZA3 H H H H 
 
Figure 1.4. Chemical structure of AZA1-3 [79]. 
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AZAs are able to accumulate in filter-feeding bivalve molluscs, such as 
mussels, oysters, clams and scallops [75]. Recently AZAs have also been 
discovered in crustaceans from Scandinavia [69]. Based on the occurrence 
and TEFs AZA1-3 have the highest biological relevance. The majority of 
AZAs in shellfish samples detected to date are AZA1 or AZA2. AZA3 is 
generally present at lower concentrations or absent. AZAs accumulate in the 
digestive gland of shellfish and from there can migrate to other parts of the 
shellfish tissue [72]. Ingestion of contaminated shellfish can lead to AZP in 
humans. Acute symptoms are similar to DSP and include vomiting, nausea, 
diarrhoea and stomach cramps. Symptoms occur within a few hours after 
consumption and last for 2-3 days before a full recovery of the clinical 
symptoms is seen. No lethality or long term effects have been reported to 
date [80]. In contrast to DSP, in vivo studies in mice also showed neurotoxin-
like symptoms, including respiratory difficulties, spasms, paralysis and death 
after i.p. injection with mussel extract [65, 66, 81]. The main target of AZA 
toxicity is the gastrointestinal tract. However, AZA1 administration to mice via 
gastric intubation also recognised the lymphatic system and the liver as 
target organs. At high concentrations AZA1 can also be found in other 
organs, including spleen, kidneys and lungs [82, 83]. This suggests that 
AZAs can be absorbed by the GI system and be distributed at least partially. 
Acute morphological changes in mice are distinctly different from other 
biotoxins. A study by Ito et al. [82] detected fluid accumulation in the small 
intestine, eroded villi in the lamina propria and epithelial cell and 
degenerating cells in the large intestine. Induction of histopathological 
changes and recovery were slower than in other biotoxins. Furthermore, the 
authors established AZA to cause fatty changes and degenerating cells in 
the liver, necrosis in lymphocytes and reduction in numbers of non-
granulocytes in the lymphoid tissue.  A recent study confirmed the findings 
for the GI tract, however failed to see any other changes in mice after AZA1 
exposure [83]. To date, in vitro studies have failed to identify the cellular 
target of AZAs. A variety of morphological changes in cell lines have been 
reported, such as loss of cell membrane integrity, flattening of cells and 
reduction of pseudopodia [84]. Alterations of the cytoskeleton, accompanied 
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with changes in cell shape and loss of cell-cell / cell-surface interactions are 
suggested to be the result of changes in the E-cadherin pool and F-actin 
levels [85-87]. Furthermore, AZAs have proven to act on the activity of 
neurons [88], decrease viability in a variety of cell lines [88-91], inhibit 
cholesterol biosynthesis [92] and change cellular cAMP levels [93-95], 
intracellular pH [94, 96] and calcium flux [94-96]. Possible implications on 
heart functions have been investigated recently in vitro, showing a blockage 
of hERG channels [97] and in vivo, demonstrating a change in heart 
physiology of rats [98]. Exposure in the latter study occurred via single 
intravenous injection at concentrations of 11 µg and 55 µg per kg body 
weight. Limited data are available on long-term toxicity and/or carcinogenicity 
of AZAs. The above mentioned study by Ito et al. [82] also investigated the 
long term effects of repeated exposure to AZA1 by oral gavage in mice. 
AZA1 was administered at concentrations ranging from 1 µg to 50 µg per kg 
body weight, twice a week, up to 40 times within 145 days. Animals in the 
higher dose groups that died or had to be sacrificed during the treatment 
showed a loss in body weight, accumulation of gas in the gastrointestinal 
organs and a range of pathological changes. The latter included 
inflammation of liver and lung, erosion in the stomach and shortened villi in 
the small intestine. A few lung tumours were observed but not further 
considered due to the high toxic effects. No illness, weakness or lung 
tumours were detectable in the animals of the lower dose groups, neither at 
the end of treatment nor after an additional three months at the end of the 
treatment. No tumours were observed after eight months of treatment in a 
follow-up study by the same authors [99] but lymphatic nodules in the lung of 
about 1/3 of the animals were detected. One quarter of the animals that were 
kept on up to a year developed malignant lymphomas or lung tumours within 
that time frame, in the control group one out of fifty-two animals. The limited 
in vivo data available are indicative of tumour promoter potential of AZAs but 
severe toxicity observed in most cases restricts the relevance of those 
findings [79, 80]. A study in Japanese medaka (Coryzias latipes) mimicking 
maternal-egg transfer investigated the teratogenic potential of AZA1. Results 
showed dose-dependent effects on heart and developmental rate, hatching 
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success and the overall survival of the embryo. Further features included a 
reduced somatic growth and yolk absorption and a delayed onset of blood 
circulation and pigmentation. Hence the authors suggest AZA1 to be a potent 
teratogen to finfish, also raising concern about possible environmental 
effects within the marine food web and eventually long term effects for 
human consumers at levels below the regulatory limit [100]. To date no data 
on the genotoxic potential of AZAs are available in the literature [79]. Most 
data available are based on acute toxicity studies, involving mainly AZA1 due 
to the lack of or limited availability of standards. For this reason the 
European Food Safety Authority (EFSA) decided on an acute reference dose 
(ARfD) of 0.2 µg AZA1 equivalent per kg body weight. Shellfish meat for 
human consumption is regulated by the Regulation (EC) No 853/2004 and 
states 160 µg AZA1 equivalent per kg shellfish meat as the maximum 
amount permitted [79, 95].  
 
Detection methods  
To protect the consumer from possible effects of phycotoxins, monitoring 
programs have been established in many European countries. These 
monitoring programs normally cover a wide range of toxins as contamination 
in shellfish is generally not restricted to one phycotoxin [8]. Both the rat 
bioassay and the mouse bioassay were regulated and standardized as the 
two main mammalian bioassays in the EU Commission Regulation (EC) No 
2074/2005 [23, 101]. The rat bioassay (RBA) does not require the extraction 
of phycotoxins as shellfish hepatopancreas or meat is mixed with regular rat 
food or directly fed to pre-starved female rats. The consistency of faeces and 
amount of food eaten is observed and marked as -, +/-, +, ++ and +++. 
Responses in rats rated as + or ++ are considered equivalent to severe 
complaints in humans involving diarrhoea and nausea. In contrast, the 
mouse bioassay (MBA) includes the extraction of phycotoxins from shellfish 
hepatopancreas or whole flesh with solvents. Mice are exposed to the extract 
via i.p. injection and the survival is monitored over time giving a simple 
positive or negative response [23, 102]. The MBA is costly, non-specific, 
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solvent dependent, lacks sensitivity and is prone to inaccuracies in detection 
and procedural variations [5]. Biological functional assays, immunological 
assays and chemical analytical assays rely on structural and chemical 
properties as opposed to toxicity and therefore the overall toxicity has to be 
calculated with the help of toxic equivalent factors (TEFs). Biological 
functional assays are based on receptors or cells and use the mechanism of 
action to quantify toxicity [5, 101]. As receptors are not necessarily specific 
for one toxin group, results can only indicate toxin activity and not 
unambiguously identify the toxin. Immunological assays rely on specific 
antibodies. Based on the structure of the antibody either a specific toxin can 
be identified or all members of a toxin family. Hence cross-reactions can be 
beneficial or a limitation, depending on the test reason. Both methods are 
rapid, simple and easy to use. Chemical analytical methods include liquid 
chromatography (LC) with fluorescence (FL), ultra violet (UV) or mass 
spectrometer (MS) detection. Although they require trained personnel, toxic 
standards which can be limited in availability and are relatively expensive, 
these chemical analytical methods, especially LC-MS are effective methods 
for the detection and quantification of phycotoxins. For this reason LC-MS 
has been adopted in 2011 by the European Commission Regulation as a 
replacement for the MBA for the monitoring of the four major phycotoxin 
families, OA, PXT, YXT and AZAs [5, 101]. 
 
Implications and assessment 
Phycotoxins do not only display an environmental and public health problem 
but also pose an economic problem [1]. Aquacultures and harvesting sites 
can be closed for a prolonged time due to the occurrence of HABs. 
Mortalities of wild or farmed fish and shellfish and implications on tourism 
have been reported. The economic impact has been estimated to be millions 
of dollars around the world [6, 9, 13, 15, 103]. Maximum levels of toxins 
permitted in shellfish are regulated in many countries and monitoring 
programs have been set in place. Recent reports on acute intoxication are 
few or non-existent [80]. However, these regulation limits and ARfDs are 
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often based on very few studies and acute toxicity data only. In 2009 the 
EFSA panel on Contaminants in the Food chain concluded, on request from 
the European Commission (EC), that the current regulation limits in the 
European Union for OA, AZAs, STX and DA are not sufficient to protect 
human consumers [61]. This conclusion was based on the comparison of the 
current EU limits for shellfish meant for the market and the acute reference 
doses (ARfDs) as recommended by the EFSA panel. Establishing 400 g of 
shellfish meat as a realistic estimate of a large portion, exposure to OA and 
the AZA-group would exceed the recommended ARfDs 3- and 5-fold, 
respectively. For STX and DA the exposure would be 10- and 4-fold, 
respectively above the recommended ARfDs. No long term reference values 
could be established due to the lack of long-term toxicity data. The panel 
proposed in its concluding remarks that the reporting system for human 
illnesses should be improved. For some toxin groups, additional information 
such as mechanism of toxicity and genotoxicity is required to fully assess 
potential risks to human consumers [23, 61, 79, 104].  
 
Genotoxicity 
Background 
Testing for genotoxicity is an essential part of hazard identification and is 
defined as the process in which the structure and/or information of the DNA 
gets altered. Such alterations to the genome can be spontaneous or through 
exposure to genotoxic agents. Genotoxicity can lead to permanent changes 
in the amount/structure of the genetic material but this is not an inevitable 
consequence [105, 106]. However, changes in the genetic material can 
trigger cell death, disturb cell homeostasis, alter cell regulation and has been 
linked to a variety of genetic diseases [31, 107]. The accumulation of DNA 
damage in cells has been proposed to play a role in degenerative conditions, 
such as immune dysfunctions and cardiovascular and neurodegenerative 
diseases. Mutations may cause cancer if DNA damage/changes occur in 
tumor suppressor cells and/or DNA response genes. Genetic alteration in 
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germ cells can result in infertility or inheritable damage which could have 
consequences for subsequent generations [31]. Carcinogenicity studies are 
relatively expensive and time consuming. Therefore genotoxic studies are 
often used as part of safety assessments to provide information on the 
potential damage to genetic material [31]. A range of in vitro and in vivo 
assays have been developed to identify substances which could trigger 
genotoxicity, inheritable damage or are able to identify the mechanism of 
action of such compounds. No assay per se is able to provide all the required 
information but can under- or overestimate the effect. This can be resolved 
using a multiple test system or so called test battery. Such test batteries 
include a variety of assays; the exact composition is dependent on the type 
of study and regulatory protocol involved. Yet all individual assays included 
complement each other, allowing for a better understanding of findings and 
more accurate recommendations concerning hazard identification [31, 108, 
109]. The sensitivity, the chance of correctly identifying a genotoxic 
compound, increases with increasing numbers of tests. Conversely, the 
specificity decreases. The higher the number of different assays performed 
the greater the likelihood of false positive results [31, 108, 110]. In vitro 
assays have a higher sensitivity than in vivo assays and the exposure of the 
target cells is guaranteed, also they do not have an ethical component. They 
are designed to detect either micro-lesions (for example point-mutations) or 
macro-lesions (clastogenic effects). Micro-lesions can be detected by assays 
such as the bacterial reverse mutation test in Salmonella typhimurium and 
Escherichia coli (Ames test, OECD guideline 471) and the in vitro 
mammalian cell gene mutation test [31, 111]. The main principle of the Ames 
test is the reversion of originally present mutations in the bacterial strains 
and their re-found ability to synthesize an essential amino acid. While parent 
strains need amino acid supplementation, if gene mutation has occurred, the 
daughter generation is able to grow without. It is a quick, easy and widely 
used method. However, it uses prokaryotic cells which are different to 
mammalian cells in a variety of factors such as their chromosome structure, 
DNA repair processes and metabolism. The in vitro mammalian cell gene 
mutation test (OECD guideline 476) on the other hand uses a variety of 
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mammalian cell lines to detect gene mutations, such as base-pair 
substitutions or frame shifts. Preference is often given to the L5178Y mouse 
lymphoma cell line assay, which additionally can detect other genetic events 
such as large deletions or mitotic recombination [31]. Macro-lesions can be 
detected by assays such as the in vitro mammalian chromosomal aberration 
(CA) test, the sister chromatid exchange (SCE) assay, the in vitro 
mammalian cell micronucleus (MN) test and the COMET assay [31]. The CA 
test detects structural aberrations, also numerical changes (polyploidy) while 
the SCE test detects, as the name states, the exchange of genetic material 
between sister chromatids, visualized through staining techniques. If an 
exchange has occurred, chromosomes have stained and non-stained areas 
and are therefore called “harlequin chromosomes”. Both assays are time 
consuming and require training [31, 112]. The MN assay is a method to 
detect clastogens and aneugens alike. Isolated or broken chromosomes form 
micronuclei if they are not excluded during cell division and can be made 
visible through DNA staining. Additional to the standard protocol (OECD 
guideline 474), kinetochore staining and fluorescent in situ hybridisation 
(FISH) can give extra mechanistic information, for example about non-
disjunction. Cytochalasin B (cytoB) addition allows assessment of cell 
proliferation. The COMET assay (described in detail below) detects overall 
DNA damage and as the MN assay, is quick and easy to perform [31, 105]. 
All in vitro tests are designed to detect one or more of the main genotoxic 
endpoints a) gene mutation b) alterations in chromosome structure 
(clastogenicity) and c) alterations in chromosome number (aneuploidy) [31, 
113]. A possible drawback with in vitro systems is the general lack of 
metabolism. No cultured cell line is able to reproduce the full 
biotransformation capacity of tissues used in in vivo tests or the whole animal 
[109]. To overcome this potential challenge, metabolic activation systems are 
often included. The most frequently used system is a cofactor-supplemented 
post-mitochondrial liver fraction (S9) of animals treated with cytochrome 
P450 enzyme inducing agents, most commonly from rats [31, 105, 109, 114]. 
Literature suggests that a metabolic activation system is not necessarily 
required for all phycotoxins [46, 51, 55]. For example, OA showed a 
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genotoxic effect in Chinese hamster lung cells without metabolic activation 
[46]. A variety of assays has been established to detect genotoxicity in vivo. 
The transgenic rodent somatic and germ cell gene mutation assay (OECD 
guideline 488) has been established for the detection of gene mutations. The 
assay uses transgenic rats and mice to measure point mutations, insertions 
and small deletions in genetically neutral marker genes, genes of no 
immediate consequence to the animal. Both the mammalian erythrocyte 
micronucleus test (OECD guideline 474) and bone marrow chromosome 
aberration test (OECD guideline 475) have been established to detect 
chromosome damage. The latter detects only structural aberrations in bone 
marrow, while the mammalian erythrocyte micronucleus test detects 
structural and numerical chromosome damage in somatic cells. The COMET 
assay and unscheduled DNA synthesis (UDS) test with mammalian liver 
cells (OECD guideline 486) have been established for the detection of 
primary DNA damage. The endpoint of the UDS test is measured by the 
uptake of labelled nucleosides and indicative of DNA adduct removal by 
repair mechanisms [31, 105].  
Recommendations have been made by several agencies such as the UK 
Committee on Mutagenicity of Chemicals in Food, Consumer Products and 
the Environment (COM) [105], the U.S. Food and Drug Administration (FDA) 
[108] and EFSA [31] to use a set number of genotoxic tests with different 
endpoints, two in vitro assays and if necessary a third in vivo assay. The 
U.S. Environmental Protection Agency (EPA) has such a test battery in 
place, comprising of a) the Ames test, b) the in vitro mammalian cell gene 
mutation assay and c) either the in vivo bone marrow mammalian 
chromosome aberration test or the in vivo erythrocytes micronucleus assay 
[31, 105, 108]. Internationally recognized protocols for both, in vitro and in 
vivo tests are available through the Organisation for Economic Co-operation 
and Development (OECD), the International Workshops on Genotoxicity 
Testing (IWGT), the U.S. Environmental Protection Agency and the EU test 
methods regulation (EC 440/2008) [31, 105].  
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The COMET assay 
The COMET assay or single-cell gel electrophoresis (SCGE) is an 
established method for the detection of DNA damage and has been 
extensively used in various (research) areas, including biomonitoring, 
ecotoxicology, fundamental DNA damage and repair research and 
genotoxicity testing [115, 116]. The assay was first developed by Ostling and 
Johanson [117] in 1984 and later modified by Singh et al. [118] in 1988. The 
general principle behind the assay is that negatively charged DNA fragments 
will migrate towards the anode if an electrical field is applied [119]. In short, 
exposed cells are embedded in agarose on a microscope slide, lysed, the 
DNA uncoiled and placed in an electrical field for a short time frame. The 
DNA is afterwards stained with a fluorescent dye, most commonly Ethidium 
bromide (EtBr) and analysed under the microscope [116]. The assay got its 
name from the appearance of the DNA of a single cell. The undamaged high 
molecular weight DNA forms the comet head, the migrated DNA fragments 
form the comet tail (Figure 1.5.). Analysis can be done visually or with the 
help of software packages, which identify fluorescent parameters of manually 
selected comets. The parameters used most commonly are tail length, 
percentage tail DNA and tail moment. The tail length increases when the 
COMET tail is first being established at relatively low damage. However, with 
increasing damage the tail intensity increases but not the tail length. Tail 
moment is the sum of the tail length and the tail intensity. Both, the tail 
moment and the tail length do not show a linear dose-response and are more 
likely to be effected by thresholds and background settings. Percentage tail 
DNA is considered the most reliable of the three parameters, as it has a 
linear relationship to strand break frequency and allows discrimination over 
the widest range [116, 120].  
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Figure 1.5. Imaging of cells after performance of the COMET assay a) a cell 
without DNA fragmentation, b) a cell with minor DNA fragmentation and c) a 
cell with major DNA fragmentation. Cells are stained with Ethidium bromide 
and images were taken under a fluorescence microscope (Nikon EFD-3, 
magnification: 40x). 
 
Two different variations of the COMET assay are in use, one in neutral 
conditions and one in alkaline conditions. The neutral assay can detect only 
single-strand breaks and double-strand breaks, while the alkaline version is 
able to detect single- and double-strand breaks as well as incomplete repair 
sites, alkali labile sites and with further modifications DNA-protein and DNA-
DNA cross links [116, 119, 121]. The COMET assay has many advantages 
compared to other tests. It is a simple, easy to use, cost effective quantitative 
and qualitative assay. It requires minimum amounts of test sample [122], 
which is especially important in relation to biotoxins. Often only small 
amounts of toxin sample isolated from shellfish extract are available and 
standards can be expensive. Detection is at a single cell level and it can be 
applied to any eukaryotic or prokaryotic cells or tissues given that a single 
cell suspension is possible. It is non-invasive when used in vivo, and shows 
a higher flexibility compared to other assays as it can be applied to 
proliferating cells as well as non-proliferating cells [115, 120, 122, 123]. The 
COMET assay (in vitro and in vivo) has shown some variability within and 
between experiments. Automated scoring systems have minimized the 
interpretation error but selection of comets is still done manually [115, 120, 
122]. Results given by the COMET assay reflect the overall damage in the 
cellular DNA based on strand breaks, independent of the mode of action. To 
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assess whether the damage visualized is based on direct genotoxicity or 
other factors, for example cytotoxicity, apoptosis or necrosis, additional 
assays should be included in the study design. This allows for the 
appropriate interpretation of the DNA fragmentation detected and its 
biological relevance [116, 119, 124].  
 
Cell death  
An integral part of in vitro assays are cell viability tests. They are essential to 
interpret data from other endpoints correctly, such as genotoxicity. Cell death 
can be a result of natural events or external factors. One of the main 
questions surrounding cell death is, “when is a cell dead?” The 
Nomenclature Committee on Cell Death (NCCD) has recommended that 
cells should be considered dead when 1) the cell membrane integrity is lost 
2) the cell and nucleus are fully disintegrated and/or 3) the cell has been 
engulfed by a neighbouring cell [125]. The loss of cell membrane integrity 
can be assessed in vitro by the exclusion of certain dyes, for example 
propidium iodide (PI) or trypan blue.  Viable cells are impermeable to trypan 
blue due to their intact cell membrane, whereas dead cells have a deficient 
cell membrane and are permeable to trypan blue. Excessive cytotoxicity has 
been shown to give a number of false positive results in a variety of assays, 
including the MN assay, CA test and COMET assay [109, 121, 126, 127]. 
Ideally a wide concentration range should be included, a highest 
concentration with a clear cytotoxic effect as well as a lower concentration 
which does not cause cytotoxicity (viabilities between 90% - 100%). If these 
requirements are met, one can be confident that observed positive results, in 
the absence of overt cytotoxicity, represent a genotoxic effect caused by the 
test compound and equally that negative results are due to lack of 
genotoxicity of the test compound and not due to limitation of the 
concentration range investigated [109, 115, 121]. An additional indication for 
cell death is the cell number. While the cell number is unchanged in case of 
genotoxic damage, the cell number is reduced during cell death based on the 
full disintegration of cells (125, 128). 
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Part of the process of cell death is the activation of biochemical cascades 
that result in a variety of morphological changes, for instance the display of 
apoptotic or necrotic features [125]. Apoptosis or “programmed cell death” 
occurs under normal circumstances as part of a balanced process to 
maintain cell populations and tissues during development and aging. 
However, it can also be triggered during immune responses or when cells 
are damaged due to diseases or external stimuli, such as toxic substances 
[129, 130]. To date, two main apoptotic pathways are distinguished 1) the 
extrinsic pathway or death receptor pathway a result of external stimuli, and 
2) the intrinsic pathway or mitochondrial pathway, a result of internal stimuli, 
for example oxidative stress and DNA damage. While there are significant 
differences between those two pathways, some features are common 
(Figure 1.6.). Both share a range of morphological and molecular changes 
that are reversible until the so called “point of no return” [125, 129, 131, 132]. 
Furthermore, both pathways lead on to the same execution pathway, 
triggered by the activation of caspase-3, a member of the cysteine-
dependent aspartate-specific protease family. Caspase-3 plays a major role 
in the cleavage of a range of cellular proteins [133]. An early marker after the 
onset of the execution pathway is the exposure of phosphatydylserine (PS). 
PS is a phospholipid component normally located in the inner leaflet of the 
plasma membrane. Due to the plasma membrane changing its structure in 
the process of apoptosis PS becomes exposed on the outer leaflet of the 
membrane. There it functions as a specific marker for macrophages and 
phagocytes [134]. This is generally followed by protease activation and 
endonuclease activity which lead to the degradation of chromosomal DNA 
and structural changes in the cytoskeleton. Chromatin condensation and 
nuclear fragmentation are later steps in the apoptotic process and finally lead 
to the formation of apoptotic bodies [132, 134]. 
In contrast to apoptosis, necrosis is characterized by an increase in cell 
volume and an early loss in cell membrane integrity. Until recently necrosis 
has been considered only an accidental and uncontrolled event but evidence 
is growing that it frequently is a well regulated process. Under special 
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conditions, ligation of death receptors, excitotoxins or alkylating DNA 
damage can trigger regulated necrosis [131, 132].  
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Figure 1.6. Overview of apoptotic events, external or internal stimuli trigger 
a cascade of changes. Both pathways share the activation of an execution 
pathway and the translocation of phosphatydylserine (PS) to the outer 
membrane, an early marker of apoptosis and DNA fragmentation, a late 
event.  
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A vast variety of methods are available to detect parameters associated with 
cell death in vitro or in vivo. Based on the aim of the study it could be feasible 
to apply a combination of complementary tests. A single test might not 
precisely demonstrate the aspect of cell death which is of interest [125]. The 
methods vary in their specificity, sensitivity, detection range, cell stage, death 
parameter and throughput. For example, light microscopy is a quick and 
easy method but lacks specificity. One of the more convenient methods is 
cytofluorometry. Different protocols have been developed using a variety of 
dyes for different endpoints. Annexin V, a phospholipid binding protein is not 
able to penetrate the plasma membrane but it has a high affinity for PS. On 
translocation of PS from the inner to the outer leaflet of the plasma 
membrane in the apoptotic process, Annexin V can bind and if conjugated 
with fluorescein isothiocyanate (FITC), a fluorescence dye, can be made 
visible in a flow cytometer. As PS translocation is considered an early 
process in the apoptotic event, Annexin V binding / FITC positive staining is 
used as an early marker of apoptosis. To discriminate apoptotic processes 
from necrotic processes membrane impermeable DNA stains such as PI are 
used in combination with Annexin-FITC. PI is unable to penetrate intact cell 
membranes and therefore cells that stain FITC positive but PI negative can 
be considered (early) apoptotic. Cells which stain both FITC positive and PI 
positive have lost their membrane stability and are therefore either necrotic 
or late apoptotic [125, 129, 134].  
 
Objectives  
Most information on the toxicity of phycotoxins is based on acute toxicity. 
Data on genotoxicity and low level exposure including long term effects are 
limited. OA has shown some genotoxic potential, however data are often 
contradictory and the involvement of cytotoxicity in the detected effects 
cannot be eliminated. As a result the data available are difficult to interpret 
(23). No long term toxicity/carcinogenicity studies have been reported but OA 
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is identified as a tumor promoter in rodents [57-60]. No genotoxicity data for 
AZAs has been reported to date [79]. Repeated toxin administration over a 
longer duration in rodents identified occasional lung tumours. These findings 
coincided with doses causing severe toxicity and therefore may be of limited 
relevance [79, 80, 82]. To fully assess the potential risk of phycotoxins on the 
environment and human consumers, information on those aspects are 
important factors.  
The aims of the present study are to investigate the genotoxic effects of OA 
and the AZA group using the COMET assay in cell lines representing the 
main target organs of these biotoxins. The COMET assay is a direct method 
that requires only a short time frame to complete, depending on the sample 
size. It can be adopted for small amounts of test substances and for a variety 
of cell lines making it ideal for biotoxin studies. The cell lines selected in this 
study were 1) Jurkat T cells (human T cell lymphoblasts), 2) CaCo-2 cells 
(human epithelial colorectal adenocarcinoma cells) and 3) HepG-2 cells 
(human hepatocellular cells). Besides representing the main target organs of 
OA and AZAs, published data indicates cell line specificity of biotoxins. The 
COMET assay analysis was complemented with cytotoxicity and apoptosis 
analysis. These assays provide information on whether the biotoxin-induced 
DNA fragmentation in the COMET assay coincides with an increase in 
cytotoxicity and/or apoptosis. Taken together, all information will allow a 
more precise interpretation of the observed effects. 
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Chapter 2: Positive controls 
Introduction 
The main goal of hazard identification is the realistic assessment of potential 
risks caused by drugs and chemicals [1]. One essential part of these safety 
assessments are tests for genotoxicity. A variety of in vitro and in vivo 
assays have been developed which are mostly easy to perform, relatively 
inexpensive, faster than carcinogenicity studies and detect a variety of 
genotoxic effects using a range of endpoints. Genotoxic compounds might 
not test positive in all assays; however there is a good overall correlation 
between the different assays [2]. In order to appropriately interpret the 
findings of any of these tests some requirements have to be met. A suitable 
concentration range has to be established, with a clear and definite positive 
and negative effect. A dose-response relationship should be detectable and 
the results should be reproducible [3]. Furthermore, negative controls and 
appropriate positive controls should be included. The crucial functions of 
negative and positive control data are the in-house establishment of the test 
system and the development of in-house background data. If provided for 
each test system, the data supports the verification of new studies or 
compounds tested [3, 4]. Usually the solvent of the test substance is used as 
the negative control. Results found in the test system are compared to the 
data found with the negative control study. Differences identified can be 
regarded as the test compound effect. Untreated samples are also often 
included to rule out any effect of the solvent on the test system [4-6]. Positive 
controls assess if the test system used is capable of detecting a known 
genotoxic agent under the current conditions. The concentration of the 
compound should give a clear positive result. However, it should not be 
associated with excessive cytotoxicity. The exact compound used, thereby 
depends on the experimental aim and the test assay. Some examples of 
positive controls used in the absence of metabolic activation (S-9 mix) are 4-
nitroquinoline-N-oxide, ethylnitrosourea (ENU), methylmethanesulfonate 
(MMS) and ethylmethanesulfonate (EMS) [3, 5, 6]. EMS has frequently been 
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used in DNA repair studies and is widely used as a positive control for 
genotoxicity testing in vitro and in vivo. It is a direct acting genotoxic agent 
which causes carcinogenic effects in mammals and mutagenic effects in 
animals and plants [3, 7, 8]. Cotelle et al. [9] found EMS to significantly 
increase DNA migration in plant cells. Other studies have found EMS to 
significantly increase the number of mutations in the HCO/HPRT assay [10], 
increase the frequency of micronuclei (MN) in flow cytometer analysis and 
DNA damage in the COMET assay [11]. EMS acts through the addition of a 
methyl group to DNA nucleotides and has been stated to cause DNA adduct 
formation, resulting in single DNA strand breaks [11-13]. Cadmium chloride 
(CdCl2) is another compound that has been reported as a good positive 
control for genotoxic testing [14-17]. It is a highly toxic metal compound [18, 
19] but has also been described in the literature as mutagenic [18], genotoxic 
and carcinogenic in human and animal cell lines [14, 19-21].  However, the 
DNA damaging effects identified in various studies are often accompanied by 
either excessive cytotoxicity [15] or reactive oxygen species (ROS) 
formation. This has led various authors to suggest that the DNA damage 
detected might be caused by indirect interactions [18, 20, 22-24]. It has also 
been proposed that CdCl2 may induce necrosis [15] or apoptosis in various 
cell lines [18, 21, 25]. Staurosporine, an alkaloid isolated from Streptomyces 
sp., is a potent inhibitor of phospholipid/calcium dependent protein kinase. It 
has the ability to rapidly induce apoptosis, via mitochondrial caspase 
activation in mammalian cells, in the absence of genotoxicity.  Staurosporine 
is therefore frequently used as an apoptosis inducing agent [26, 27].  
The aim of the present study was the establishment of in house reference 
data for the assays used in subsequent studies on marine biotoxins. The 
positive controls chosen are characterized above. The assays and the 
decision as to which cell lines to use have been described in greater detail in 
Chapter 1. In brief, the COMET assay was selected as the detection method 
for genotoxicity. It has many advantages to other assays, such as being 
quick, easy to use and requiring only little test compound. It can furthermore 
be performed on various cell types if a single cell suspension is possible. 
Chapter 2: Positive controls 
40 
 
This is of importance when investigating differences in tissue responses to 
compounds. The additional analysis of cytotoxicity assisted in assigning the 
correct concentration range as well as with the interpretation of data. It 
allowed determining whether DNA damage detected was a positive 
genotoxic result or the result of overt cytotoxicity. The use of flow cytometer 
analysis was included to investigate early and late apoptosis as an 
alternative explanation for the observed DNA damage. 
  
Materials & Methods 
Chemicals & Reagents 
All chemicals were purchased from Sigma-Aldrich, Ireland unless otherwise 
indicated. Annexin V and Annexin V detection kit, flow tubes and flow 
cytometer fluids were obtained from BD Bioscience, UK. Microscope slides 
and cover slips were purchased from Fisher Scientific, Ireland. All plastic 
ware was acquired from Sarstedt, Ireland. 
 
Cell culture 
Jurkat T cells (human T cell lymphoblasts), CaCo-2 cells (human epithelial 
colorectal adenocarcinoma cells) and HepG-2 cells (human hepatocellular 
cells) were obtained from the European Collection of Cell Cultures (ECACC, 
operated by Public Health England). Jurkat T cells were cultured in RPMI-
1640 medium supplemented with 10% fetal bovine serum (FBS), 2 mM L-
glutamine and 50 mg/mL gentamicin. CaCo-2 cells and HepG-2 cells were 
maintained in DMEM medium supplemented with 10% FBS and 1% 
penicillin/streptomycin. Additionally, 1% non-essential amino acids (NEAA) 
were added for CaCo-2 cells. All cell lines were cultured at 37°C in a 5% CO2 
humidified incubator (Forma Scientific Infrared CO2 incubator, Biosciences, 
Ireland). Non-adherent cells were kept in upright standing 25 cm2 
polystyrene tissue culture flasks; adherent cell lines were kept in 75 cm2 
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polystyrene tissue culture flasks. The passage numbers used for all cell lines 
were between 15 and 30. 
Adherent cells were passaged when reaching 80-90% confluence. The 
medium was aspirated and the cells were washed with phosphate buffered 
saline (PBS). PBS was aspirated and cells were incubated for 5 minutes with 
trypsin-EDTA (0.25%) to allow cell detachment. Trypsin was neutralised by 
addition of complete medium and the cell suspension was then centrifuged at 
400 g for 5 minutes. The cell pellet was re-suspended in complete medium 
and 10% of the cells were then re-seeded in a new flask containing complete 
medium. Non-adherent cells were passaged every 2-3 days at a starting 
density of 1 x 105 cells/mL.  
 
Cell exposure 
The stock solutions of 1 mM and 5 mM cadmium chloride (CdCl2) were made 
up in double distilled water and 50 mM and 250 mM of 
ethylmethanesulfonate (EMS) were prepared in serum free medium. Both 
stocks were kept at 4° C until use. Stock solutions of EMS were prepared 
fresh after a month due to the half-life given by the product information sheet 
provided by Sigma-Aldrich, Ireland. Staurosporine was purchased as 1 mM 
solution dissolved in DMSO. The chemicals were added at 2% v/v of the total 
volume in the well; serial dilutions were performed where needed to keep the 
added volume consistent. 
For experiments, cells were seeded in 6 well plates at a density of 2 x 105 
cells/mL, with a total of 2 mL per well. Adherent cells were seeded the night 
before (to allow re-attachment) while non-adherent cells were seeded 4 
hours prior to exposure. The final concentrations initially used for CdCl2 were 
20 µM and 100 µM. Lower concentrations were included for CaCo-2 (5 µM) 
and HepG-2 cells (1 µM and 5 µM) due to low viabilities/reduction in cell 
number observed at 20 µM and 100 µM in initial experiments. All three cell 
lines were exposed to 1 mM and 5 mM EMS. Based on concentrations 
established in the literature [27, 28, 29] Jurkat T cells were furthermore 
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exposed to Staurosporine at a final concentration of 2.5 µM (0.25% v/v) and 
5 µM (0.5% v/v). Blanks were included in each experiment, either containing 
the corresponding vehicle or being vehicle free. The exposure time for 
Staurosporine was 2 hours. The initial exposure time for all other 
experiments was 24 hours. Based on initial results, exposure times of 48 
hours for Jurkat T cells and CaCo-2 cells and 12 hours for HepG-2 cells were 
included in this study.  
 
Trypan Blue Dye Exclusion assay 
The cell viability was determined by the Trypan Blue Dye Exclusion assay 
following the protocol by Strober [30] with slight modifications. Aliquots (100 
L) of the cell suspension were transferred to Eppendorf cups, mixed with a 
0.4% trypan blue solution (1:1) and applied to a haemocytometer. The 
viability was calculated4 as the percentage of viable cells (trypan blue 
negative) of the total cell number (trypan blue negative plus trypan blue 
positive). All cell counts were performed in duplicates.  
 
COMET assay 
Alkaline single cell gel electrophoresis was performed following the protocol 
by Woods et al. [31]. In brief, the exposure medium (2mL) was transferred to 
Eppendorf tubes and centrifuged, the adherent cells were detached as 
described before. Cell pellets from the exposure medium, if existent, and 
detached cells were re-suspended together in 1 mL of complete medium. 
Non-adherent cell samples were taken directly out of the wells. In the case of 
low cell numbers the suspension was centrifuged (400 g, 5 minutes) and re-
suspended in 100 µL medium. Microscope slides were pre-coated with 30 µL 
1% normal-melting agarose (NMA) in PBS and allowed to dry. Onto those 
                                                          
4 Calculation of total cell number:  
Cells/mL = (average count/square) x 2 (dilution factor) x 10 000 (chamber conversion factor) 
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slides 100 µL of NMA was added, a cover slip applied (22 x 22 mm) and 
allowed to solidify on ice. The cover slip was removed and an aliquot of the 
cell suspension (30 µL) was mixed with 1% low-melting point agarose (LMA, 
70 µL) in PBS and transferred to the prepared microscope slide. The slides 
were allowed to solidify on ice before being immersed in a lysis solution (2.5 
M NaCl, 100 mM EDTA, 10 mM Tris, 90 mM sodium sarcosinate, containing 
10 % (v/v) DMSO and 1 % (v/v) Triton X-100) for a minimum of 1 hour at 2-
8ºC in the dark. The lysis solution was stored at 4ºC for at least 1 hour prior 
to use. Slides were then transferred to a horizontal electrophoresis tank and 
immersed in an alkaline solution (200 mM EDTA (pH 10), 10 N NaOH ) for 
30 minutes. Electrophoresis was carried out for exactly 25 minutes at 22 V 
and 300 mA. Slides were then neutralised three times for 5 minutes with 0.4 
M Tris (pH 7.5) and stained with Ethidium bromide (EtBr, 20 g/mL) for 5 
minutes.  Slides were washed with double distilled water (ddH2O) for 5 
minutes before being stored in a fridge until analysis. Storage under damp 
conditions gave reliable data up to 4 days. In total 50 cells per slide were 
scored and the percentage of tail DNA was used to determine the degree of 
DNA fragmentation. All samples were analysed in duplicate and a total of 
four independent experiments were performed for each cell line, chemical 
and exposure time. The analysis was performed using imaging analysis 
software package Komet 4.0 (Kinetic Imaging Ltd). 
 
Flow cytometer analysis  
Samples for flow cytometer analysis were prepared according to the 
instruction on the technical data sheet provided by BD Pharming, with slight 
modifications [32]. Non-adherent and adherent cells were transferred to 15 
mL tubes and washed twice with cold PBS. The cells were re-suspended in 
400 µL binding buffer, 200 µL if the cell pellet was small. An aliquot of 100 L 
was then transferred to a flow tube. Five µL of FITC Annexin V and 5 µL of 
PI staining solution were added to each sample and stored at room 
temperature, in the dark for 15 minutes. After staining 400 µL of binding 
buffer was added and samples were analysed on a flow cytometer within 1 
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hour. Analysis was carried out on a FACSCanto (Becton Dickinson, UK), a 
two-laser (Octagon, 488 nm blue laser; Trigon, 633 nm red laser), six-colour 
instrument. The excitation wavelength used for both dyes was 488 nm. The 
emission for FITC was detected in the FL1 channel (Filter 530/30), for PI in 
the FL2 channel (Filter 630/22) (Figure 2.1.) [33]. All samples were analysed 
in duplicates and a total of four independent experiments were performed for 
all cell lines, chemicals and exposure times. 
 
 
Figure 2.1. Overview of the fluorescence spectra of fluorescein 
isothiocyanate (FITC) and propidium iodide (PI). The dotted curves 
represent the excitation spectra of FITC and PI and the solid colour curves 
the emission spectra. The excitation wavelength for both dyes on a 
FACSCanto is 488 nm; the emission for FITC is detected in the FL1 channel 
(530/30) and for PI in the FL2 channel (630/22) [33].  
 
The FACS Diva program allows the display of results either as pulse area, 
width or height. The pulse area is the total signal given by the particle, while 
the pulse height is the maximum signal intensity. The pulse width gives the 
transit time and therefore the size or aggregation of cells. The pulse area for 
two cells stuck together however is double the pulse area for a single cell, 
yet the pulse height is essentially the same [34]. In this study pulse height 
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was chosen as display method to exclude any possible interference of cell 
aggregation.  
Gating was used as a method to provide differentiation between the actual 
cell population and cell debris. To define the borders of the cell population 
more precisely, results were displayed in histograms (forward scatter (FSC) 
vs. cell count); the gained information was then applied to gate off the main 
cell population. The gate for the main cell population was first defined on the 
two blanks. Taking the information of the histograms into account, all other 
samples were then double checked to see if their main cell population would 
fall within the gate. Once this was established the gate for the main cell 
population was kept constant. Defining the borders of the cell population had 
to be repeated for each independent experiment (Figure 2.2.).  
 
(a)                                                         (b) 
 
Figure 2.2. Example of flow cytometer data obtained in this study. Data is 
displayed a) as histogram (FSC vs. cell count) and b) as cluster. The cluster 
display includes the gate for the main cell population which is based on the 
borders indicated in the histogram. 
 
For both stains the borders for classification of positive and negative cells in 
the main population, were established using histograms of stains vs. cell 
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count. Using the histograms as guideline allowed a more precise and 
consistent definition of the quadrant borders within one experiment. The 
quadrant borders had to be defined for each independent experiment. Once 
applied, the percentage of cells in each quadrant could be calculated and 
displayed (Figure 2.3.).  
 
(a)            (b) 
 
(c)           (d) 
 
Figure 2.3. Example of flow cytometer data obtained in this study. Data is 
displayed a) schematic, b) as cluster, c) as histogram for FITC (vs. cell 
count) and d) as histogram for PI (vs. cell count). The cluster (b) shows the 
actual quadrants which are based on the boarders given in the two 
histograms. 
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Viable cells would stain both FITC and PI negative, early apoptotic cells 
would stain FITC positive only, late apoptotic/necrotic cells would stain both 
FITC and PI positive. Technically no cells should stain PI positive only. 
However, in some cases a small amount of cells could be detected in the 
upper left quadrant. This is most likely due to physical damage caused by the 
treatment prior to analysis [35]. 
A total of 10,000 cells were counted per sample. All samples were performed 
in duplicate and a total of four experiments were performed for each cell line, 
chemical and exposure time. 
 
Statistical analysis 
Statistical analysis was carried out using IBM SPSS Statistics 20. Data were 
expressed as mean ± standard deviation (SD) of four independent 
experiments. Outliers were identified by box plots and where clearly related 
to an experimental error, removed. Differences between means were 
established using the non-parametric Kruskal-Wallis-Test with Mann-Whitney 
U test for pairwise comparison. Results were considered significantly 
different with a p-value ≤ 0.05 (*), 0.01 (**) and 0.001 (***). Correlation 
between cell viability based on Trypan Blue Exclusion assay data and on 
flow cytometer data (FITC- / PI- plus FITC+ / PI-) was analysed using the 
Spearman´s rank correlation in Graph Pad Prism 5. 
 
Results 
The effect of positive controls on Jurkat T cells. 
Jurkat T cells were exposed to different concentrations of EMS for 24 and 48 
hours. No statistically significant (p ≥ 0.05) effect on the cell number could be 
seen after 24 hours of exposure. The cell number at 5 mM however was 
reduced to 79%. A significant reduction (p ≤ 0.01) could be shown for both 
concentrations at 48 hours (Table 2.1.) 
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Table 2.1. Cell number of Jurkat T cells, expressed as % of the blank, after 
exposure to EMS at 2 different concentrations for 24 hours and 48 hours. Results 
are the mean ± SD of 4 independent experiments and were considered significantly 
different with a p-value < 0.05 (*), 0.01 (**) and 0.001 (***).  
 
 
Assay Exposure  Blank EMS  EMS 
  
Time 
   
1 mM 
 
5 mM 
 
 
Trypan Blue 
Exclusion 
assay 
24 hours 
 
 
100  
 
 
87 ± 25 
 
 
79 ± 10 
 
 
 
48 hours 
 
 
100  
 
 
82 ± 11 
(**) 
 
71 ± 17 
(**) 
 
 
 
No reduction in cell viability (p ≥ 0.05) could be detected at either time point 
(Figure 2.4.a). Comparing viability data from the Trypan Blue Exclusion 
assay and flow cytometer analysis (sum of FITC- / PI- and FITC+ / PI- 
stained cells) gave correlation coefficients (r) of 1 (ns) for 24 hours and 0.8 
(ns) for 48 hours. A significant increase (p ≤ 0.001) in FITC+ / PI- stained 
cells (early apoptosis) could only be noticed after 48 hours for EMS at a 
concentration of 5 mM (Figure 2.4.c). A significant increase in FITC+ / PI+ 
stained cells (late apoptosis/necrosis) could be detected at the highest 
concentration at both time points (24 hours p ≤ 0.01, 48 hours p ≤ 0.01). A 
significant increase in DNA fragmentation could be seen for both 
concentrations (1 mM p ≤ 0.05, 5 mM p ≤ 0.001) of EMS after 24 hours, 
whereas no significant difference (p ≥ 0.05) could be identified after 48 hours 
exposure (Figure 2.4.b). 
 
Chapter 2: Positive controls 
49 
 
24 h 48 h
B
la
nk
1 
m
M
5 
m
M
B
la
nk
1 
m
M
5 
m
M
0
20
40
60
80
100
(a)
V
ia
b
il
it
y
 (
%
)
24 h 48 h
B
la
nk
1 
m
M
5 
m
M
B
la
nk
1 
m
M
5 
m
M
0
20
40
60
80
100
*
***
(b)
%
 t
a
il
 D
N
A
 
24 h 48 h
B
la
nk
1 
m
M
5 
m
M
B
la
nk
1 
m
M
5 
m
M
0
20
40
60
80
100 FITC- / PI-
FITC+ / PI-
FITC+ / PI+
***
(c)
FITC- / PI+
P
e
rc
e
n
ta
g
e
 o
f 
c
e
lls
 
Figure 2.4. The effect of EMS on Jurkat T cells after 24 and 48 hour 
exposure a) on cell viability b) on DNA fragmentation and c) on 
apoptosis/necrosis. The different concentrations are compared to the blank 
and significance is marked as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 
For flow cytometer analysis significances are only marked for FITC+ / PI- 
stained cells (early apoptosis). Results presented are the mean ± SD of 4 
independent experiments. 
 
 
Exposure to different concentrations of CdCl2 showed a significant reduction 
(p ≤ 0.05) in cell number at the highest concentration ( p ≤ 0.05) after 24 
hours and at both concentrations after 48 hours (20 µM p ≤ 0.05 and 100 µM 
p ≤ 0.01) (Table 2.2.). 
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Table 2.2. Cell number of Jurkat T cells, expressed as % of the blank, after 
exposure to CdCl2 at 2 different concentrations for 24 hours and 48 hours. Results 
are the mean ± SD of 4 independent experiments and were considered significantly 
different with a p-value < 0.05 (*), 0.01 (**) and 0.001 (***).  
 
 
Assay Exposure  Blank CdCl2  CdCl2 
  
Time 
   
20 µM 
 
  100 µM 
 
 
Trypan Blue 
Exclusion 
assay 
24 hours 
 
 
100  
 
 
95 ± 17 
 
 
48 ± 18 
(*) 
 
 
48 hours 
 
 
100 
 
 
69 ± 20 
(*) 
 
20 ± 4 
(**) 
 
 
 
A strong significant decrease (p ≤ 0.01) in cell viability could be detected for 
100 M at both time points (Figure 2.5.a). Comparing viability data given by 
flow cytometer analysis (FITC- / PI- plus FITC+ / PI-) and the Trypan Blue 
assay showed a correlation coefficient of r = 0.5 (ns) for 24 hours and r = 1 
(ns) for 48 hours. A significant increase in FITC+ / PI- stained cells (early 
apoptosis) could be detected for 20 µM (p < 0.05) and 100 µM (p < 0.01) 
after 24 hour exposure. However, no significant increase (p ≥ 0.05) in FITC+ 
/ PI- stained cells (early apoptosis) could be seen after 48 hours. This lack of 
FITC+/PI- stained cells (early apoptosis) coincides with a significant increase 
(p < 0.001) in FITC+ / PI+ stained cells (late apoptosis/necrosis) (Figure 
2.5.c). Cells displayed a significant increase in DNA fragmentation for 100 
µM (p ≤ 0.001) at 24 hours and for 20 µM (p ≤ 0.05) and 100 µM (p ≤ 0.001) 
at 48 hours (Figure 2.5.b). The increase in tail DNA in the COMET assay 
coincides with the above mentioned decrease in viability as well as the 
increase in FITC+ / PI+ stained cells (late apoptosis/necrosis) detected by 
flow cytometer analysis. 
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Figure 2.5. The effect of CdCl2 on Jurkat T cells after 24 and 48 hour 
exposure a) on cell viability b) on DNA fragmentation and c) on 
apoptosis/necrosis. The different concentrations are compared to the blank 
and significance is marked as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 
For flow cytometer analysis significances are only marked for FITC+ / PI- 
stained cells (early apoptosis). Results presented are the mean ± SD of 4 
independent experiments.  
 
 
Exposure to different concentrations of Staurosporine for 2 hours showed no 
significant (p ≥ 0.05) effect on cell number (Table 2.3.) but a reduction to 
approximately 80% compared to the blank could be identified. 
 
 
 
Chapter 2: Positive controls 
52 
 
Table 2.3. Cell number of Jurkat T cells, expressed as % of the blank, after 
exposure to Staurosporine at 2 different concentrations for 2 hours. Results are the 
mean ± SD of 4 independent experiments and were considered significantly 
different with a p-value < 0.05 (*), 0.01 (**) and 0.001 (***).  
 
Assay Exposure  Blank Staurosporine  Staurosporine 
  
Time 
   
2.5 µM 
 
5 µM 
 
Trypan Blue 
Exclusion assay 
 
 
2 hours 
 
 
100 
 
 
81 ± 16 
 
 
82 ± 24 
 
 
     
 
 
No effect of Staurosporine could be seen on cell viability (Figure 2.6.a). 
Correlation analysis between viability data from flow cytometer analysis 
(FITC- / PI- plus FITC+ / PI-) and the Trypan Blue Exclusion assay gave a 
coefficient of r = 0.9 (ns). A significant increase in FITC+ / PI- stained cells 
(early apoptosis) could be detected for both concentrations (2.5 µM p ≤ 0.01 
and 5 µM p ≤ 0.001) by flow cytometer analysis (Figure 2.6.c). No change in 
FITC+ / PI+ stained cells (late apoptosis/necrosis) could be detected. A 
significant increase (p ≤ 0.01) in DNA fragmentation could be seen for both 
concentrations (Figure 2.6.b).  
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Figure 2.6. The effect of Staurosporine on Jurkat T cells after 2 hour 
exposure a) on cell viability b) on DNA fragmentation and c) on 
apoptosis/necrosis. The different concentrations are compared to the blank 
and significance is marked as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 
For flow cytometer analysis significances are only marked for FITC+ /PI- 
stained cells (early apoptosis). Results presented are the mean ± SD of 4 
independent experiments. 
 
 
The effect of positive controls on CaCo-2 cells. 
CaCo-2 cells were exposed to different concentrations of EMS for 24 and 48 
hours. No significant decrease (p ≥ 0.05) in cell number could be detected at 
24 hours; however the cell number at a concentration of 5 mM was 71%. A 
significant reduction (p ≤ 0.01) in cell number could be seen at 5 mM after 48 
hours of exposure (Table 2.4.). 
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Table 2.4. Cell number of CaCo-2 cells, expressed as % of the blank, after 
exposure to EMS at 2 different concentrations for 24 hours and 48 hours. Results 
are the mean ± SD of 4 independent experiments and were considered significantly 
different with a p-value < 0.05 (*), 0.01 (**) and 0.001 (***).  
 
 
Assay Exposure  Blank EMS  EMS 
  
Time 
   
1 mM 
 
5 mM 
 
 
Trypan Blue 
Exclusion 
assay 
 
24 hours 
 
 
 
100 
 
 
 
98 ± 20 
 
 
 
71 ± 14 
 
 
 
48 hours 
 
 
100 
 
 
98 ± 23 
 
 
67 ± 15 
(**) 
 
 
 
No significant reduction (p ≥ 0.05) in cell viability could be detected at any 
time point (Figure 2.7.a). Comparing the viability data from flow cytometer 
analysis (FITC- / PI- plus FITC+ / PI- data) and Trypan Blue Exclusion assay 
gave a correlation coefficient of r = 1 (ns) for 24 hours and r = 0.5 (ns) for 48 
hours exposure. A significant change (p ≤ 0.05) in FITC+ / PI- stained cells 
(early apoptosis) could be detected after 48 hours for EMS at a concentration 
of 1 mM (Figure 2.7.c). No significant changes could be detected for FITC+ / 
PI+ stained cells (late apoptosis/necrosis). After 24 and 48 hours a significant 
increase in DNA fragmentation could be identified for both concentrations (1 
mM p ≤ 0.05 and 5 mM p ≤ 0.001) (Figure 2.7.b). 
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Figure 2.7. The effect of EMS on CaCo-2 cells after 24 and 48 hour 
exposure a) on cell viability b) on DNA fragmentation and c) on 
apoptosis/necrosis. The different concentrations are compared to the blank 
and significance is marked as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 
For flow cytometer analysis significances are only marked for FITC+ / PI- 
stained cells (early apoptosis). Results presented are the mean ± SD of 4 
independent experiments.  
 
 
Exposure to different concentrations of CdCl2 for 24 and 48 hours showed a 
significant reduction (p ≤ 0.01) in cell number for the two highest 
concentrations at 24 hours and for 100 µM after 48 hours (p ≤ 0.01). 
Although not statistically significant (p ≥ 0.05), a reduction in cell number 
could also be seen at 20 µM at 48 hours (Table 2.5.). 
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Table 2.5. Cell number of CaCo-2 cells, expressed as % of the blank, after 
exposure to CdCl2 at 3 different concentrations for 24 hours and 48 hours. Results 
are the mean ± SD of 4 independent experiments and were considered significantly 
different with a p-value < 0.05 (*), 0.01 (**) and 0.001 (***).  
 
Assay Exposure  Blank CdCl2  CdCl2  
 
CdCl2 
  
Time 
   
5 µM 
 
20 µM 
 
100 µM 
  
 
Trypan Blue 
Exclusion 
assay 
24 hours 
 
 
100 
 
 
93 ± 9 
 
 
70 ± 10 
(**) 
 
24 ± 11 
(**) 
 
 
48 hours 
 
 
100 
 
 
106 ± 6 
 
 
68 ± 12 
 
 
38 ± 5 
(**) 
 
 
 
A significant decrease in cell viability could be detected at both time points 
for 20 µM (p ≤ 0.05) and 100 µM (24h p ≤ 0.01, 48h p ≤ 0.001) (Figure 
2.8.a). Correlation analysis between the Trypan Blue Exclusion assay and 
the viability data given by flow cytometer analysis (FITC- / PI- plus FITC+ / 
PI-) gave coefficients of r = 0.8 (ns) for 24 hours and r = 1 (ns) for 48 hours 
exposure. No significant increase (p ≥ 0.05) in FITC+ / PI- stained cells (early 
apoptosis) could be identified (Figure 2.8.c). A significant increase in FITC+ / 
PI+ stained cells (late apoptosis/necrosis) could be shown for 100 µM CdCl2 
(p ≤ 0.01) at 24 hours and 20 µM (p ≤ 0.01) and 100 µM (p ≤ 0.001) at 48 
hours (Figure 2.8.c). A minor percentage of FITC- / PI+ stained cells could 
be identified for 100 µM at 24 hours and 20 µM and 100 µM at 48 hours of 
exposure. A significant increase (p ≤ 0.001) in DNA fragmentation could be 
detected at 24 hours and 48 hours at the two highest concentrations (Figure 
2.8.b) This increase coincides with the above mentioned decrease in cell 
viability and increase in FITC+ / PI+ stained cells (late apoptosis/necrosis).  
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Figure 2.8. The effect of CdCl2 on CaCo-2 cells after 24 and 48 hour 
exposure a) on cell viability b) on DNA fragmentation and c) on 
apoptosis/necrosis. The different concentrations are compared to the blank 
and significance is marked as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 
For flow cytometer analysis significances are only marked for FITC+ / PI- 
stained cells (early apoptosis). Results presented are the mean ± SD of 4 
independent experiments.  
 
 
The effect of different positive controls on HepG-2 cells. 
HepG-2 cells were exposed to different concentrations of EMS for 12 and 24 
hours. No significant decrease (p ≥ 0.05) in cell number could be seen at any 
concentration or time point. However, the cell number at 5 mM after 48 hours 
is 62% (Table 2.6.). 
 
B
la
nk
 M
5 
M
20
 
M
10
0 
B
la
nk
 M
5 
M
20
 
M
10
0 
0
20
40
60
80
100 FITC- / PI-
FITC+ / PI-
FITC+ / PI+
FITC- / PI+
24 h 48 h(c)
P
e
rc
e
n
ta
g
e
 o
f 
c
e
ll
s
Chapter 2: Positive controls 
58 
 
Table 2.6. Cell number of HepG-2 cells, expressed as % of the blank, after 
exposure to EMS at 2 different concentrations for 12 hours and 24 hours. Results 
are the mean ± SD of 4 independent experiments and were considered significantly 
different with a p-value < 0.05 (*), 0.01 (**) and 0.001 (***).  
 
 
Assay Exposure  Blank EMS  EMS 
  
Time 
   
1 mM 
 
5 mM 
 
 
Trypan Blue 
Exclusion 
assay 
 
24 hours 
 
 
 
100 ± 0 
 
 
 
106 ± 16 
 
 
 
97 ± 30 
 
 
 
48 hours 
 
 
100 ± 0 
 
 
92 ± 29 
 
 
62 ± 26 
 
 
 
 
No reduction in cell viability could be detected (Figure 2.9.a). Comparing the 
viability given by flow cytometer analysis (sum of FITC- / PI- and FITC+ / PI- 
stained cells) and the Trypan Blue Exclusion assay showed coefficients of r = 
0.8 (ns) for 12 hours and r = 0.5 (ns) for 24 hours of exposure. No significant 
increase  (p ≥ 0.05) in either, FITC+ / PI- (early apoptosis) or FITC+ / PI+ 
stained cells (late apoptosis/necrosis) could be seen (Figure 2.9.c). At 24 
hours of exposure all concentrations, including the blank, show a minor 
percentage of FITC- / PI+ stained cells. A significant increase in DNA 
fragmentation could be identified for both concentrations (1 mM p ≤ 0.05, 5 
mM p ≤ 0.001) of EMS after 24 hours (Figure 2.9.b). 
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Figure 2.9. The effect of EMS on HepG-2 cells after 12 and 24 hour 
exposure; a) on cell viability b) on DNA fragmentation and c) on 
apoptosis/necrosis. The different concentrations are compared to the blank 
and significance is marked as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). 
For flow cytometer analysis significances are only marked for FITC+ / PI- 
(early apoptotic) cells. Results presented are the mean ± SD of 4 
independent experiments. 
  
 
Exposure to different concentrations of CdCl2 for 12 and 24 hours showed a 
significant reduction in cell number at the two highest concentrations (20 µM 
p ≤ 0.05 and 100 µM p ≤ 0.01) after 12 hours and at 5 µM and 100 µM (p ≤ 
0.05) after 24 hours. Although not significant (p ≥ 0.05), the cell number at 48 
hours for a concentration of 20 µM is 49% (Table 2.7.). 
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Table 2.7. Cell number of HepG-2 cells, expressed as % of the blank, after 
exposure to CdCl2 at 4 different concentrations for 12 hours and 24 hours. Results 
are the mean ± SD of 4 independent experiments and were considered significantly 
different with a p-value < 0.05 (*), 0.01 (**) and 0.001 (***).  
 
 
Assay Exposure  Blank CdCl2  CdCl2 
 
CdCl2 
 
CdCl2 
  
Time 
   
1 µM 
 
5 µM 
 
20 µM 
 
100 µM 
  
 
Trypan Blue 
Exclusion 
assay 
12 hours 
 
 
100 ± 0 
 
 
99 ± 13 
 
 
70 ± 3 
 
 
34 ± 7 
(*) 
 
31 ± 16 
(**) 
 
 
24 hours 
 
 
100 ± 0 
 
 
122 ± 20 
 
 
34 ± 011 
(*) 
 
49 ± 18 
 
 
41 ± 11 
(*) 
 
 
 
 A significant decrease in cell viability could be detected at both time points 
for 20 µM (p ≤ 0.05) and 100 µM (p ≤ 0.001) (Figure 2.10.a). Although not 
statistically significant (p ≥ 0.05), a clear decrease can also be seen for 5 µM 
at 24 hours.  Comparing the viability data obtained by Trypan Blue Exclusion 
Assay and flow cytometer analysis (FITC- / PI- plus FITC+ / PI- data) gave 
correlation coefficients of r = 0.9 (ns) at both time points. A significant 
increase in FITC+ / PI- stained cells (early apoptosis) could only be identified 
for 20 µM (p ≤ 0.001) after 12 hours (Figure 2.10.c). A minor percentage of 
FITC- / PI+ stained cells could be identified for all concentrations, including 
the blank at 24 hours of exposure. A significant increase in DNA 
fragmentation could be detected for 20 µM and 100 µM at 12 hours (p ≤ 
0.001) and 5 µM (p ≤ 0.05), 20 µM (p ≤ 0.001) and 100 µM (p ≤ 0.001) at 24 
hours (Figure 2.10.b). The increase in tail DNA coincides strongly with the 
above mentioned decrease in cell viability and with a significant increase in 
FITC+ / PI+ stained cells (late apoptosis/ necrosis) as measured by flow 
cytometer analysis. The only exception is CdCl2 at a concentration of 5 µM. 
The viabilities given by the Trypan Blue Exclusion assay and the tail DNA 
given by the COMET assay coincide. However, the percentage of FITC+ / 
PI+ stained cells (late apoptosis/necrosis) at 12 hours is higher than the 
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viabilities would indicate and at 24 hours lower than the viabilities would 
indicate. 
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Figure 2.10. The effect of CdCl2 on HepG-2 cells after 12 and 24 hour 
exposure; a) on cell viability b) on DNA fragmentation and c) on apoptosis. 
The different concentrations are compared to the blank and significance is 
marked as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). For flow cytometer 
analysis significances are only marked for FITC+ / PI- stained cells (early 
apoptosis. Results presented are the mean ± SD of 4 independent 
experiments.  
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Discussion 
The principle of the COMET assay is the visualization of DNA damage. On 
application of an electrical field, low weight DNA strands will migrate away 
from the nucleus and form the comet tail while the undamaged DNA does not 
migrate and forms the comet head. This migration can then be visualized 
with fluorescent dyes and informs about DNA damage caused by the test 
compound(s). The main purpose of the present study was to establish and 
validate a) the methodologies used and b) to generate in house reference 
data for the interpretation of future genotoxic studies. Three cell lines, Jurkat 
T, CaCo-2 and HepG-2 were exposed to EMS, a direct genotoxic agent [7], 
CdCl2 a compound widely used as positive control in genotoxic testing [14-
17] and Staurosporine, a non-genotoxic apoptosis inducer [34]. The COMET 
assay, Trypan Blue Exclusion assay and flow cytometer analysis were 
performed on all cell lines and compounds. 
Attempts were made to ensure that the mixing of cells and the sampling of 
aliquots for the Trypan Blue Exclusion assay were as constant as possible. 
Slight variations are likely. While this would not affect the cell viability per se, 
it might well account for higher standard deviations (SD) in cell numbers.  
EMS caused no significant decrease in viability in all three cell lines. The 
percentage of viable cells determined by flow cytometer analysis was lower 
than by the Trypan Blue Exclusion assay. The reason for this discrepancy is 
most likely due to the preparation of samples for flow cytometer analysis. 
This involves several centrifugation and pipetting steps which might 
introduce some physical damage to the cell membrane [35]. No cytotoxic 
effect could be identified at the concentration range tested (1 mM and 5 mM). 
Normally in toxicity testing a concentration range up to cytotoxicity is applied. 
Concentrations for EMS are well established in the literature and followed in 
this study. Furthermore, no additional concentrations were necessary based 
on the detection of DNA damage in the COMET assay at both 
concentrations, in the absence of cytotoxicity. In case of HepG-2 cells, no 
DNA fragmentation could be detected at 12 hours of exposure to EMS. A 
significant dose dependent increase in DNA fragmentation of 20% for 1 mM 
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EMS and 50-65% for 5 mM EMS after 24 hours was detected in all three cell 
lines (Figure 2.4.b, 2.7.b, 2.9.b). The percentage in tail DNA after 48 hours 
of exposure for Jurkat T cells and CaCo-2 cells is lower than after 24 hours. 
Repair mechanisms following EMS exposure have been reported in the 
literature in vivo and in vitro [11, 37-39] and could account for the 
observations made in the present study. One criterion for genotoxic damage 
and possible repair mechanisms is an unchanged cell number [40]. In the 
current study, the cell numbers for 1 mM, especially at 24 hours but also in 
most cases for 48 hours (Table 2.1., 2.4., 2.6.) are above 80% (compared to 
the blank) and therefore support the suggested DNA repair. For 5 mM, 
especially for HepG-2 cells the cell number is between 60% and 80% 
compared to the blank. Cell loss could be a possible explanation. Floating 
cells in the exposure media could have been missed before active 
detachment. In the present study, flow cytometer analysis showed no 
significant increase in early apoptosis (FITC+ / PI-) in all three cell lines, at 
both concentrations and all time points. EMS has been widely used as a 
positive control for genotoxicity testing in vitro and in vivo in various 
organisms, including human cell lines. It is a direct acting, DNA damaging 
agent which causes a concentration dependent increase in DNA damage [7, 
12, 41, 42]. The clear positive genotoxic response achieved with EMS in the 
present study is in agreement with the above literature and established the 
COMET assay as an in-house method to detect DNA damage in subsequent 
biotoxin studies. 
All three cell lines were exposed to a concentration range of CdCl2 that has 
been reported widely in the literature and demonstrated a significant dose 
and time dependent decrease in cell viability [22, 24, 43]. These findings 
could be confirmed. CaCo-2 cells and HepG-2 cells seemed to be the most 
affected in the present study. The exposure concentration had to be lowered 
to 5 µM and 1 µM to allow for a broader concentration range, showing 
cytotoxic and non-cytotoxic effects (Figures 2.5.a, 2.8.a, 2.10.a). 
Comparison between viability data obtained by the Trypan Blue Exclusion 
assay and flow cytometer analysis showed good correlation with coefficients 
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close to 1. Although not statistically significant, this is most likely of biological 
relevance. Within the concentration range (1 µM – 100 µM), the COMET 
assay showed a significant increase in DNA fragmentation at both time 
points for all three cell lines (Figures 2.5.b, 2.8.b, 2.10.b). However, HepG-2 
cells seemed to be the most sensitive cell line showing a statistically 
significant increase in DNA fragmentation at concentrations of 5 µM after 24 
hours. This is in agreement with other published findings [14, 18, 19, 44]. No 
data on cytotoxicity or cell number were reported in these publications. In the 
current study, the cell number for all three cell lines decreased substantially 
in a concentration and time dependent matter (Tables 2.2, 2.5, 2.7). In case 
of direct genotoxic damage the cell number should stay consistent [40]. 
Therefore, the cell loss described here indicates rather apoptotic 
mechanisms to have taken place. This is supported by flow cytometer 
analysis undertaken in the present study. Results showed a significant 
increase in early apoptosis (FITC+ / PI-) in Jurkat T cells after 24 hour 
exposure at both concentrations (20 µM and 100 µM, Figure 2.5.c). HepG-2 
cells showed a significant increase in early apoptosis after 12 hours at a 
concentration of 20 µM (Figure 2.10.c). The lack of a significant percentage 
of early apoptotic cells at 48 hours for Jurkat T cells and 24 hours for HepG-2 
cells indicated a time dependent shift from early apoptosis to late apoptosis. 
CaCo-2 cells showed no indication of early apoptosis, but a significant 
increase in late apoptosis/necrosis (Figure 2.8.c). Recent papers have 
demonstrated that Cd/CdCl2 can not only induce DNA strand breaks but also 
induce apoptosis in various cell lines [22, 25, 43, 44]. DNA fragmentation is 
also a biochemical marker of apoptosis [47-49] and can therefore be 
detected in the COMET assay. The percentage of tail DNA detected in the 
present study correlates well with the percentage of late apoptotic cells 
(FITC+ / PI+). Bacso and Eliason [50] found that FITC+ / PI+ stained Jurkat 
cells (late apoptosis/necrosis) had measurable comets in the COMET assay 
while only few comets could be detected for FITC+ / PI- stained cells (early 
apoptosis). This is supported by Elmore et al. [47] and other publications on 
apoptosis [51-53], which state DNA fragmentation as a late event in 
apoptosis. The data obtained for CdCl2 in the present study seems to 
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indicate a cytotoxic as well as apoptotic effect in at least two of the three cell 
lines. This effect is most likely responsible for the DNA damage detected in 
the COMET data. To verify the possible connection between apoptosis and 
visible DNA fragmentation in the COMET assay Jurkat T cells were exposed 
to Staurosporine, a known apoptosis inducer which does not have a direct 
effect on the genome [36]. Flow cytometer analysis showed a significant 
increase in early apoptosis for both concentrations of Staurosporine (Figure 
2.6.c) verifying it as an apoptosis inducer. No significant reduction in cell 
viability could be shown for any of the concentrations (Figure 2.6.a). Also, no 
significant reduction in cell number could be detected after 2 hours at either 
concentration (Table 2.3.). The decrease in cell number to about 80% at 2.5 
and 5 µM is more likely a result of the handling procedure than of great 
biological relevance. However, the COMET assay showed a statistically 
significant yet modest increase in DNA fragmentation for both concentrations 
(Figure 2.5.b). DNA fragmentation is a late apoptotic event; however no 
significant amount of late apoptotic cells (FITC+ / PI+) could be detected in 
this study. The concentrations and exposure durations are in agreement with 
the literature and so are the results detected in the present study. DNA 
fragmentation as a result of Staurosporine has been demonstrated by 
Bertrand et al. [26] and Belmokhtar et al. [29], the latter who concluded that 
Staurosporine induces cell death via a caspase dependent pathway in Jurkat 
T cells and DNA fragmentation being a biochemical marker of apoptosis. The 
percentage of tail DNA detected in the current study is about 20%, while the 
amount of early apoptotic cells (FITC- / PI+) is approximately 80%. CdCl2 
also shows an increase in early apoptotic cells (FITC+ / PI-) in the absence 
of cytotoxicity and only minimal amounts (~ 10%) of late apoptotic cells 
(FITC+ / PI+). One possible explanation could be that these cells have 
undergone the complete apoptotic process and are almost completely 
fragmented and do not consist of a cell membrane anymore. Therefore, they 
would not have stained FITC+ / PI+ in the present study and would not have 
been recognised. The findings in the present study are supported by Roser 
et al. [54]. The authors found the relative numbers of apoptotic cells to be 
three fold higher than the DNA fragmentation detected in HT-29 colon 
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adenocarcinoma cells. They concluded that apoptosis does not necessarily 
coincide with DNA damage shown by the COMET assay. However, the ratio 
may differ depending on cell line and concentration.  
Comparing the different cell lines with each other, EMS gave similar time and 
response profiles in all three cell lines for all endpoints. Lung, kidney and 
liver are reported in the literature as main target organs for Cd toxicity [24, 
43, 55]. Skipper et al. [56] showed a 24h-LD50 of 3.6 µg/mL for CdCl2 and a 
significant increase in DNA fragmentation, concluding CdCl2 to be highly 
cytotoxic to HepG-2 cells. This is in agreement with results found in the 
current study. HepG-2 cells showed the earliest and strongest response of all 
three cell lines used. A significant decrease in cell viability and a significant 
increase in DNA fragmentation and early apoptosis could be detected after 
12 hours of exposure. Jurkat T cells and CaCo-2 cells showed DNA 
fragmentation of similar percentages after 24 hours, Jurkat T cells also 
showed a significant increase in early apoptosis. No increase in early 
apoptosis could be detected for CaCo-2 cells even after 48 hours; however, 
an earlier significant decrease in cell viability could be seen. This is in 
agreement with findings by Boveri et al. [15]. In their study CaCo-2 cells 
showed necrotic cell death after 24 hours at a concentration of 50 µM, while 
no variation in apoptosis could be detected. Apoptosis induction is often 
linked to oxidative stress [24, 19]; however, Boveri et al. [15] and Noda et al. 
[56] were unable to link CdCl2 exposure to oxidative stress in CaCo-2 cells. 
Another possible explanation for the different responses detected in this 
study could be variable amounts of endonucleases, which in term lead to 
different levels of apoptosis induction [43].  
Technically no cells should stain FITC- / PI+. However, a small percentage 
could be detected for CaCo-2 cells at the highest concentration of CdCl2 at 
both time points and HepG-2 cells with all chemical and concentrations at 24 
hours, including the blank. This might be due to handling and preparation of 
cells (centrifugation, re-suspension) prior to flow cytometer analysis [33]. 
Again there are differences between the cell lines, no FITC- / PI+ stained 
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cells could be detected for Jurkat T cells. This might indicate possible 
damage due to cell detachment. 
Conclusion 
The COMET assay is a reliable and rapid method for the detection of 
genotoxic effects. It has been generally assumed that the DNA fragmentation 
seen in the COMET assay coincides with the damage done to the genome 
[58]. Recent studies, including this one have shown that DNA fragmentation 
which occurs during apoptosis/necrosis can be detected in the COMET 
assay [29, 58-60]. Therefore, the results presented here indicate the 
importance of the right positive control. In this study the COMET assay could 
be verified as a method for DNA damage using EMS, a direct DNA damaging 
compound. However, CdCl2 which is also widely used as a positive control 
may be inducing DNA fragmentation indirectly through apoptotic processes 
and could therefore lead to false positive results in the COMET assay. 
Results of this study stress the importance of including cytotoxicity and 
apoptosis studies in genotoxicity testing to avoid false positive results due to 
other factors than direct DNA strand breaks.  
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Chapter 3: Okadaic acid 
Introduction 
Okadaic acid (OA) is a marine biotoxin produced by the dinoflagellates of the 
genus Dynophysis sp. and Prorocentrum sp.. It has been reported globally 
but the main areas where it seems to occur are Europe and Japan [1, 2]. OA 
is a polyether fatty acid, heat stable and due to its lipophilic nature able to 
accumulate in shellfish, mainly in filter feeding molluscs. It is the main cause 
for Diarrhoeic Shellfish Poisoning (DSP) in humans causing acute symptoms 
including diarrhoea, vomiting, stomach cramps, nausea and abdominal 
pains. Symptoms occur rapidly within minutes to hours and last up to a few 
days [3-5]. Human intoxication with OA is an increasing global problem and 
occurs mainly through the consumption of fishery produce. Not all cases are 
severe and therefore reported, leading researchers to believe that the 
amount of affected individuals is higher than recorded [6]. Information on 
acute toxicity is available for humans and European regulations have been 
set in place, focusing on the gastrointestinal symptoms. In vivo studies have 
shown OA to be widely distributed in mice after oral administration, the 
gastrointestinal tract being the main target [7-9]. It has also been detected in 
the liver as soon as 5 minutes after oral or i.p. administration [5] and 
enterohepatic circulation has been suggested to have taken place [10]. 
However, liver damage in general has not been reported [5, 11]. Data on the 
genotoxic potential in vitro are often contradictory and no data on chronic or 
subchronic effects in humans have been reported [6]. In vitro studies have 
identified OA to be a potent inhibitor of serine/threonine protein 
phosphatases (PP1 and PP2A) in mammalian cells. The resulting 
hyperphosphorylation of proteins leads to a disruption in many cellular 
processes and can result in a total collapse of regulatory processes [4, 6, 9, 
12]. Morphological changes have frequently been reported as a 
consequence of OA toxicity, including cell rounding, cell-cell and cell-surface 
detachment and disruption of the cytoskeleton [2, 12-14]. Various studies 
have examined the genotoxic potential of OA (Figure 3.1.), which have been 
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described in greater detail in Chapter 1. In brief, the Ames test proved 
negative while the Chinese hamster lung (CHL) cells, Chinese hamster ovary 
cells and human lymphoblastoid cells showed direct genotoxic effects.  
These toxic effects have been identified through sister-chromatid exchange 
and chromosome condensation [15, 16]. Data by Fessard et al. [17] support 
those findings. The authors detected DNA adduct formation at non-cytotoxic 
levels. Other studies have come to different conclusions. Le Hegerat et al. 
showed OA to disturb the mitotic spindle and induce premature sister 
chromatid separation. The authors suggested an aneugenic potential rather 
than a direct mutagenic potential of OA [9, 18]. This was supported by data 
from other studies which showed the loss of whole chromosomes, 
centromere-positive micronuclei and confirmed the lack of primary DNA 
damage [8, 9, 19].  
 
 
Figure 3.1. Schematic overview of the genotoxic effects of okadaic acid 
(OA) [20]. 
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DNA strand 
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Romero et al. [20] and Valdiglesias et al. [6] reported OA to interfere with 
DNA repair mechanisms. Various publications have linked both oxidative 
damage and effects on metabolic/anabolic pathways to OA toxicity [4, 21-
23]. Decrease in membrane potential and the activation of caspase-3 have 
been associated with OA, leading authors to conclude that OA might induce 
apoptosis/necrosis [13, 24-26]. Some data indicates the need for metabolic 
activation for OA to exert its mutagenic effect [27] while others showed OA to 
act directly [28]. A study by Souid-Mensi et al. [29] along with other reports 
have proposed that the effect of OA is cell line dependent [22, 29-31]. It has 
been suggested that the contradicting information on genotoxicity of OA 
might reflect the complex mechanisms involved [6]. OA has been identified 
as a tumour promoter in rodents [3, 32, 33]. A 2-stage carcinogenesis study 
by Suganuma et al. [32] found OA to induce tumours on the skin of mice and 
in the stomach of rats. Furthermore OA was found to prompt tumour necrosis 
factor  (TNF-). The tumour promotion effect of OA raises concern about 
the effects for human shellfish consumers, including chronic exposure and 
exposure to concentrations below the current regulation limit [4, 34].  
 
The purpose of the present study was to investigate the possible genotoxic 
effects of OA using the COMET assay. To explain possible DNA damage 
detected correctly, additional assays have been included (see previous 
chapters). Based on reports suggesting that the effect of OA is cell line 
dependent, work was conducted on three different cell lines, Jurkat T cells 
(immune system), CaCo-2 cells (intestine), HepG-2 cells (liver). They were 
chosen because they represent the main target organs of OA toxicity.  
 
 
Chapter 3: Okadaic acid 
76 
 
Materials & Methods 
Chemicals & Reagents 
Okadaic acid (OA) was purchased from LC Laboratories, USA and verified 
using a certified standard solution of OA (14.3 µg/mL) obtained from the 
National Research Council Halifax, Canada (Figure 3.2.). The verification 
was performed by the Mass Spectrometry Research Centre for Proteomics 
and Biotoxins (PROTEOBIO), Cork Institute of Technology. All chemicals 
were obtained from Sigma-Aldrich, Ireland except otherwise indicated. 
Annexin V and Annexin V detection kit, flow tubes and flow cytometer fluids 
were purchased from BD Bioscience, UK. Microscope slides and cover slips 
were acquired from Fisher Scientific, Ireland. All plastic ware was purchased 
from Sarstedt, Ireland. 
 
 
Figure 3.2. Standardization of OA via Liquid Chromatography-Mass 
Spectroscopy (Thermo Scientific Quantum Discovery Max triple quadropole 
mass spectrometer, heated electrospray ionization source, hyphenated to a 
Thermo Scientific Accela LC system). The analysis was conducted by the 
Mass Spectrometry Research Centre for Proteomics and Biotoxins 
(PROTEOBIO), Cork Institute of Technology [35].  
 
Cell culture 
Jurkat T cells (human T cell lymphoblasts), CaCo-2 cells (human epithelial 
colorectal adenocarcinoma cells) and HepG-2 cells (human hepatocellular 
carcinoma cells) were provided by the European Collection of Cell Cultures 
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(ECACC, operated by Public Health England) and cultured as described in 
Chapter 2. 
 
Cell exposure 
OA was dissolved in methanol at a stock concentration of 70 µg/mL. Prior to 
each experiment, working solutions were freshly prepared by serial dilution to 
keep the volume added to each well consistent. 
For experiments, cells were seeded in 6 well plates at a density of 2 x 105 
cells/mL. Adherent cells were seeded the night before (to allow re-
attachment) while non-adherent cells were seeded 4 hours prior to exposure. 
All cell lines were exposed to a final concentration of 3 ng/mL, 10 ng/mL, 33 
ng/mL and 100 ng/mL OA. Blanks were included in each experiment, either 
containing the vehicle (methanol) or being vehicle free. The exposure times 
for Jurkat T cells and CaCo-2 cells were 24 hours and 48 hours, the 
exposure times for HepG-2 cells were 12 hours and 24 hours. The reduced 
exposure times for HepG-2 cells was based on a substantial reduction in cell 
number at 24 hours in initial experiments. 
 
Assay analysis 
The Trypan Blue Exclusion assay, COMET assay and flow cytometer 
analysis were performed as described in Chapter 2. All cell counts and 
sample analysis were performed in duplicate and a total of four independent 
experiments were performed for each cell line and exposure time. 
 
Statistical Analysis 
Statistical analysis was carried out using IBM SPSS Statistics 20. Data were 
expressed as mean ± standard deviation (SD) of four independent 
experiments. Outliers were identified by box plots. If the outlier could clearly 
be identified as the result of experimental error, it was removed. Differences 
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between means were established using the non-parametric Kruskal-Wallis-
Test with Mann-Whitney U test for pairwise comparison. Results were 
considered significantly different with a p-value < 0.05 (*), 0.01 (**) and 0.001 
(***). Correlation between Trypan Blue Exclusion assay data and flow 
cytometer data (FITC- / PI- plus FITC+ / PI-) was analysed using the 
Spearman´s rank correlation in Graph Pad Prism 5. 
 
Results 
The effect of okadaic acid on Jurkat T cells. 
Jurkat T cells were exposed to four different concentrations of OA for 24 
hours and 48 hours. No significant differences (p ≥ 0.05) between the blank 
and vehicle blank could be detected at any time point for all endpoints. 
Therefore the vehicle blank is used as reference blank when presenting the 
findings of this study. A significant reduction (p ≤ 0.01) in cell number could 
be seen for 33 and 100 ng/mL of OA at both time points. Although not 
statistically significant (p ≥ 0.05) a substantial reduction in cell number could 
also be seen for 10 ng/mL of OA at both time points (Table 3.1.).  
 
Table 3.1. Cell number of Jurkat T cells, expressed as % of the blank, after 
exposure to OA at four different concentrations for 24 hours and 48 hours. Results 
are the mean ± SD of 4 independent experiments and were considered significantly 
different with a p-value < 0.05 (*), 0.01 (**) and 0.001 (***).  
 
Assay Exposure  Blank OA  OA  OA  
 
OA  
  
Time 
   
3 ng/mL 
 
10 ng/mL 
 
33 ng/mL 
 
100ng/mL 
  
Trypan Blue 
Exclusion assay 
 
 
24 hours 
 
 
100 
 
 
102 ± 30 
 
 
69 ± 30 
 
 
53 ± 6 
(**) 
 
50 ± 17 
(**) 
 
 
48 hours 
 
 
100 
 
 
108 ± 10 
 
 
34 ± 14 
 
 
15 ± 5 
(**) 
 
16 ± 4 
(**) 
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A significant decrease in cell viability could be detected for 33 ng/mL and 100 
ng/mL OA at both time points (24h, p ≤ 0.05, 48h p ≤ 0.01) (Table 3.2.). The 
viabilities, as measured by flow cytometer analysis (the sum of FITC- / PI- 
and FITC+ / PI- stained cells) correlated well with the viabilities given by the 
Trypan Blue Exclusion assay with correlation coefficients of r = 0.8 (ns) for 
24 hours and r = 1 (p ≤ 0.05) for 48 hours of exposure. A significant increase 
in FITC+ / PI+ stained cells (late apoptosis/necrosis) could be detected for 
the three highest concentrations at both time points (24h p ≤ 0.05 (10 ng/mL) 
and p ≤ 0.01, 48h p ≤ 0.001) (Figure 3.3.c, 3.3.d). A discrepancy with the 
reduction in viability observed with the Trypan Blue Exclusion assay (Table 
3.2.) can be seen at 10 ng/mL of OA, especially at 48 hours.  
 
Table 3.2. Viability of Jurkat T cells after exposure to OA at four different 
concentrations for 24 hours and 48 hours. Results are the mean ± SD of 4 
independent experiments and were considered significantly different with a p-value 
< 0.05 (*), 0.01 (**) and 0.001 (***).  
 
Assay Exposure  Blank Blank  OA  OA  OA  
 
OA  
  
Time 
   
Vehicle 
 
3 ng/mL 
 
10 ng/mL 
 
33 ng/mL 
 
100ng/mL 
  
Trypan Blue 
Exclusion assay 
 
 
24 hours 
 
 
98 ± 1.7 
 
 
99 ± 0.8 
 
 
99 ± 1.3 
 
 
100 ± 1.0 
 
 
94 ± 2.0 
(*) 
 
87 ± 7.4 
(*) 
 
 
48 hours 
 
 
100 ± 0.6 
 
 
99 ± 0.6 
 
 
99 ± 0.5 
 
 
95 ± 6.0 
 
 
57 ± 11.2 
(**) 
 
66 ± 4.8 
(**) 
 
 
 
A significant increase in FITC+ / PI- stained cells (early apoptosis) could be 
identified for the three highest concentrations (10 ng/mL p ≤ 0.01, 33 and 
100 ng/mL p ≤ 0.001) after 24 hours and for all concentrations after 48 hours 
of exposure to OA (3 and 33 ng/mL p ≤ 0.01, 10 and 100 ng/mL p ≤ 0.001). A 
significant increase in DNA fragmentation could be shown for 3 ng/mL (p ≤ 
0.05), 33 ng/mL (p ≤ 0.01) and 100 ng/mL (p ≤ 0.001) at 24 hours of 
exposure and for all concentrations, except the lowest concentration at 48 
hours (10 ng/mL p ≤ 0.05, 33 and 100 ng/mL p ≤ 0.001). The level and 
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increase in percentage of tail DNA were both lower after 48 hours (Figure 
3.3.a, 3.3.b).  
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Figure 3.3. The effect of OA on DNA fragmentation in Jurkat T cells after a) 
24 hours and b) 48 hours and on apoptosis/necrosis after c) 24 hours and d) 
48 hours. The different concentrations are compared to the blank and 
significance is marked as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). For 
flow cytometer analysis significances are only marked for early apoptosis. 
Results presented are the mean ± SD of 4 independent experiments. 
 
 
The effect of okadaic acid on CaCo-2 cells. 
A significant decrease in cell number could be detected for the two highest 
concentrations (33 ng/mL p ≤ 0.01, 100 ng/mL p ≤ 0.001) at both time points. 
Additionally a substantial reduction in cell number can be seen at a 
concentration of 10 ng/mL of OA at 24 hours and 48 hours (Table 3.3.). 
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Table 3.3. Cell number of CaCo-2 cells, expressed as % of the blank, after 
exposure to OA at four different concentrations for 24 hours and 48 hours. Results 
are the mean of ± SD 4 independent experiments and were considered significantly 
different with a p-value < 0.05 (*), 0.01 (**) and 0.001 (***).  
 
Assay Exposure  Blank OA  OA  OA  
 
OA  
  
Time 
   
3 ng/mL 
 
10 ng/mL 
 
33 ng/mL 
 
100ng/mL 
  
Trypan Blue  
Exclusion assay 
 
 
24 hours 
 
 
100 
 
 
82 ± 15 
 
 
73 ± 28 
 
 
42 ± 20 
(**) 
 
30 ± 10 
(***) 
 
 
48 hours 
 
 
100 
 
 
102 ± 9 
 
 
67 ± 20 
 
 
32 ± 6 
(**) 
 
24 ± 4 
(***) 
 
 
 
At 24 hours of exposure a significant change in cell viability could only be 
seen for 33 ng/mL OA (p ≤ 0.05). At 48 hours a significant, concentration 
dependent, decrease (10 ng/mL p ≤ 0.01, 33 and 100 ng/mL p ≤ 0.001) could 
be seen for the three highest concentrations (Table 3.4.). The viabilities, as 
measured by flow cytometer analysis (the sum of FITC- / PI- and FITC+ / PI- 
stained cells) correlated well with viability data given by the Trypan Blue 
Exclusion assay, with correlation coefficients of r = 0.9 (p ≤ 0.05) at both time 
points. A significant increase in FITC+ / PI+ stained cells (late 
apoptosis/necrosis) could be shown for 100 ng/mL (p ≤ 0.001)  of OA after 
24 hours and at the two highest concentrations after 48 hours (p ≤ 0.001) of 
exposure (Figure 3.4.c, 3.4.d). FITC- / PI+ positive stained cells could be 
identified at the three highest concentrations at 48 hours (Figure 3.4.d). 
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Table 3.4. Viability of CaCo-2 cells after exposure to OA at four different 
concentrations for 24 hours and 48 hours. Results are the mean ± SD of 4 
independent experiments and were considered significantly different with a p-value 
< 0.05 (*), 0.01 (**) and 0.001 (***).  
 
 
Assay Exposure  Blank Blank  OA  OA  OA  OA  
  
Time 
   
Vehicle 
 
3 ng/mL 
 
10 ng/mL 
 
33 ng/mL 
 
100ng/mL 
  
Trypan Blue  
Exclusion 
assay 
24 hours 
 
 
99 ± 0.5 
 
 
99 ± 0.5 
 
 
99 ± 0.5 
 
 
99 ± 1.2 
 
 
 
94 ± 3.0 
(*) 
 
95 ± 1.7 
 
 
 
48 hours 
 
 
98 ± 1.5 
 
 
100 ± 0.0 
 
 
96 ± 2.2 
 
 
92 ± 1.8 
(**) 
 
72 ± 2.9 
(***) 
 
60 ± 2.2 
(***) 
 
 
 
A significant increase in FITC+ / PI- stained cells (early apoptosis) could be 
detected for the two highest concentrations at 24 hours (33 ng/mL p ≤ 0.05, 
100 ng/mL p ≤ 0.001), no significant increase could be seen after 48 hours 
(Figure 3.4.c, 3.4.d). A significant increase in DNA fragmentation given by 
the COMET assay could be detected for concentrations of 10 (p ≤ 0.01), 33 
and 100 ng/mL (p ≤ 0.001) at both time points. The percentage of tail DNA 
for 33 and 100 ng/mL was substantially higher at 48 hours than at 24 hours 
(Figure 3.4.a, 3.4.b). The increase in tail DNA and the lack of FITC+ / PI- 
stained cells (early apoptosis) at 48 hours both coincided well with the earlier 
mentioned increase in FITC+ / PI+ stained cells.  
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Figure 3.4. The effect of OA on DNA fragmentation in CaCo-2 cells after a) 
24 hours and b) 48 hours and on apoptosis/necrosis after c) 24 hours and d) 
48 hours. The different concentrations are compared to the blank and 
significance is marked as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). For 
flow cytometer analysis significances are only marked for early apoptosis. 
Results presented are the mean ± SD of 4 independent experiments. 
 
 
The effect of okadaic acid on HepG-2 cells. 
After 12 hours of exposure to OA a significant reduction in cell number could 
be identified for the three highest concentrations (10 and 33 ng/mL p ≤ 0.05, 
100 ng/mL p ≤ 0.01). After 24 hours a significant reduction (p ≤ 0.01) in cell 
number could be detected for 33 and 100 ng/mL. Although not statistically 
significant (p ≥ 0.05) a substantial decrease in cell number could also be 
seen for the lower two exposure concentrations (Table 3.5.) 
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Table 3.5. Cell number of HepG-2 cells, expressed as % of the blank, after 
exposure to OA at four different concentrations for 12 hours and 24 hours. Results 
are the mean ± SD of 4 independent experiments and were considered significantly 
different with a p-value < 0.05 (*), 0.01 (**) and 0.001 (***).  
 
Assay Exposure  Blank OA  OA  OA  
 
OA  
  
Time 
   
3 ng/mL 
 
10 ng/mL 
 
33 ng/mL 
 
100ng/mL 
  
Trypan Blue 
Exclusion assay 
 
 
12 hours 
 
 
100 
 
 
89 ± 23 
 
 
71 ± 22 
(*) 
 
68 ± 14 
(*) 
 
53 ± 26 
(**) 
 
 
24 hours 
 
 
100 
 
 
75 ± 28 
 
 
58 ± 23 
 
 
38 ± 11 
(**) 
 
30 ± 20 
(**) 
 
 
 
A significant change (p ≤ 0.01) in cell viability could only be detected at a 
concentration of 33 ng/mL at both time points (Table 3.6.). The viabilities, as 
measured by flow cytometer analysis (the sum of FITC- / PI- and FITC+ / PI- 
stained cells) correlated well with the viabilities given by the Trypan Blue 
Exclusion assay, with correlation coefficients of r = 0.9 at 12 hours (ns) and r 
= 1 (p ≤ 0.05) at 24 hours of exposure. A significant increase in FITC+ / PI+ 
stained cells (late apoptosis/necrosis) could be detected for the three highest 
concentrations at 24 hours (10 ng/mL p ≤ 0.05, 33 ng/mL p ≤ 0.01, 100 
ng/mL p ≤ 0.001) (Figure 3.5.d). A discrepancy with the results given by the 
Trypan Blue Exclusion assay (Table 3.6.) can be seen for 10 and 100 ng/mL. 
FITC- / PI+ stained cells could be identified for the two highest 
concentrations at 12 hours and at all concentrations, except 100 ng/mL after 
24 hours, including the blank (Figure 3.5.c, 3.5.d). 
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Table 3.6. Viability of HepG-2 cells after exposure to OA at four different 
concentrations for 12 hours and 24 hours. Results are the mean ± SD of 4 
independent experiments and were considered significantly different with a p-value 
< 0.05 (*), 0.01 (**) and 0.001 (***).  
 
 
Assay Exposure  Blank Blank  OA  OA  OA  OA  
  
Time 
   
Vehicle 
 
3 ng/mL 
 
10 ng/mL 
 
33 ng/mL 
 
100ng/mL 
 
Trypan Blue  
Exclusion 
assay 
 
12 hours 
 
 
98 ± 1.2 
 
 
97 ± 0.6 
 
 
96 ± 1.2 
 
 
94 ± 2.1 
 
 
92 ± 2.4 
(**) 
 
95 ± 2.4 
 
 
 
24 hours 
 
 
99 ± 0.0 
 
 
99 ± 0.0 
 
 
99 ± 1.0 
 
 
99 ± 1.3 
 
 
94 ± 2.9 
(**) 
 
96 ± 3.4 
 
 
 
 
A significant increase in FITC+ / PI- stained cells (early apoptosis) were only 
detected at 24 hours for concentrations of 33 ng/mL (p ≤ 0.01) and 100 
ng/mL (p ≤ 0.001) (Figure 3.5.d). A significant increase in DNA 
fragmentation could be shown for the three highest concentrations (10 and 
33 ng/mL p ≤ 0.001, 100 ng/mL p ≤0.01) of OA after 24 hours of exposure 
(Figure 3.5.b). This increase in the percentage of tail DNA coincided with the 
increase in FITC+ / PI+ stained cells (late apoptosis/necrosis) above 
described. No significant change (p ≥ 0.05) for any of the endpoints, except 
cell viability, could be identified at 12 hours of exposure (Figure 3.5.a, 3.5.c) 
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Figure 3.5. The effect of OA on DNA fragmentation in HepG-2 cells after a) 
12 hours and b) 24 hours and on apoptosis/necrosis after c) 12 hours and d) 
24 hours. The different concentrations are compared to the blank and 
significance is marked as * (p < 0.05), ** (p < 0.01) and *** (p < 0.001). For 
flow cytometer analysis significances are only marked for early apoptosis. 
Results presented are the mean ± SD of 4 independent experiments. 
 
 
Discussion 
Okadaic acid (OA) is a polyether fatty acid produced by dinoflagellates of the 
genus Dynophysis sp. and Prorocentrum sp.. Together with its analogues, 
DTX1-3 it forms the group of OA-toxins [3, 23]. Due to their lipophilic nature 
these toxins can accumulate in shellfish and cause Diarrhoeic Shellfish 
Poisoning in humans after consumption [3, 7]. Literature regarding OA 
toxicity is limited; most data available are based on acute toxicity studies. 
The information available on the genotoxic potential of OA is incomplete and 
often contradicting. Because of that the main focus of the present study was 
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to identify the possible genotoxicity of OA in the COMET assay. Previous 
chapters have outlined the reasoning behind including additional assays.  
Attempts were made to ensure that the mixing of cells and the sampling of 
aliquots for the Trypan Blue Exclusion assay were as constant as possible. 
Slight variations are likely. While this would not affect the cell viability per se 
it might well account for higher standard deviations (SD) in cell numbers.  
Comparison between viability data obtained by the Trypan Blue Exclusion 
assay and flow cytometer analysis showed good correlation, with coefficients 
close to 1 for all three cell lines and time points. The absence of statistical 
power for most coefficients could be due to the sample number. Correlations 
however, are most likely of biological relevance. Discrepancies between the 
two assays, for example Jurkat T cells at 10 ng/mL after 48 hours, are 
probably a result of differences in the handling and preparation processes 
(centrifugation, re-suspension prior to flow analysis).  
Jurkat T cells showed a significant reduction in cell viability for the highest 
two concentrations at both time points. The cell viabilities after 48 hours are 
overall much lower than after 24 hours (Table 3.2.), demonstrating a dose- 
and time-dependent effect of OA on cell viability. A significant effect of OA on 
DNA fragmentation could be detected at 3 ng/mL, 33 ng/mL and 100 ng/mL 
after 24 hours. The lower tail DNA at 10 ng/mL compared to 3 ng/mL cannot 
be explained clearly. Most likely experimental errors are responsible rather 
than biological reasons. A significant increase in tail DNA after 48 hours of 
exposure to OA could be shown for the three highest concentrations (Figure 
3.3.b), however the percentage of DNA fragmentation is lower than after 24 
hours (Figure 3.3.a). This could be an indication for DNA repair mechanisms 
to have taken place. Looking at the cell numbers (Table 3.1.), it can be seen 
that there is a clear decrease in the cell number from 24 hours to 48 hours of 
exposure. For instance, at 24 hours, cell cultures exposed to 100 ng/mL had 
a cell number of 50% compared to the blank. After 48 hours a cell number of 
16% was observed compared to the blank. As previously described in 
Chapter 1 and Chapter 2, this cell loss over the time course points towards 
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apoptotic mechanisms, rather than repair mechanisms being responsible for 
the decrease in DNA damage [36]. In the present study, this is supported by 
data given by flow cytometer analysis. A significant increase in early 
apoptotic cells (FITC+ / PI-) could be detected for the three highest 
concentrations of OA after 24 hours and for all four concentrations after 48 
hours. The percentage in early apoptosis however was lower after 48 hours. 
The latter coincides with a significant increase in late apoptosis/necrosis 
(FITC+ / PI+) at the three highest concentrations after 48 hours (Figure 
3.3.d). Because of heterogeneity and differences in phases of the cell cycle, 
individual cells within the same cell population can undergo apoptotic events 
at different times [37]. This can be seen by the significant increase in late 
apoptotic/necrotic cells (FITC+ / PI+) at 33 and 100 ng/mL after 24 hours 
(Figure 3.3.c) and is further supported by the cell number. The total number 
of exposed cells is already significantly lower at 24 hours compared to the 
blank. 
CaCo-2 cells showed a statistically significant reduction in cell viability at 33 
ng/mL after 24 hours of exposure to OA. The percentage of viable cells is 
94%, hence the decrease is most likely of limited biological relevance. After 
48 hours a dose dependent effect could be detected, with significant 
reductions at 10 ng/mL, 33 ng/mL and 100 ng/mL (Table 3.4.). Different 
methods of detection and time points make a direct comparison of cell 
viabilities mentioned in the literature and those detected in the current study 
difficult. This may account for the differences seen. The cell viability in the 
present study is ≥ 90% after 24 hours of exposure, while literature reports 
viabilities between 65% (100 ng/mL) [2] and 85% (8 ng/mL) [9]. In principle it 
can be said that the reduction in cell viability in the present study is lower 
than reported in the literature [2, 8, 9, 21, 29, 34]. A significant increase in 
DNA fragmentation could be detected in the COMET assay for the two 
highest concentrations at both time points (Figure 3.4.a, 3.4.b). However, 
the percentage of tail DNA after 48 hours was approximately double than 
after 24 hours. These data indicate a time and dose dependent genotoxic 
effect of OA on CaCo-2 cells. However, one criterion for genotoxic DNA 
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damage is that the total cell number remains constant [36]. In the current 
study, a significant reduction in cell number could be seen already at 24 
hours for 33 and 100 ng/mL (Table 3.3.), which decreases even further at 48 
hours. Together with data from the flow cytometer analysis this indicated an 
apoptotic rather than genotoxic effect of OA. A significant increase in early 
apoptosis (FITC+ / PI-) could be seen by flow cytometer analysis for 33 
ng/mL and 100 ng/mL after 24 hours. At 48 hours, no significant early 
apoptosis (FITC+ / PI-) could be seen but a significant increase in late 
apoptosis (FITC+ / PI+) for the two highest concentrations could be shown. 
This suggested a progression from early to late apoptosis (Figure 3.4.c, 
3.4.d).  
HepG-2 cells showed a statistically significant reduction in cell viability as 
determined by the Trypan Blue Exclusion assay at both time points at a 
concentration of 33 ng/mL. The values (Table 3.6.) however, indicate that 
they might not be of major biological significance at the time points and 
concentrations tested. Studies conducted by other researchers have shown 
a significant increase in cytotoxicity of OA on HepG-2 cells at similar 
concentrations and time points used in this study [2, 22, 23, 28, 29]. This 
discrepancy could possibly be explained by the different detection methods 
used. No increase in DNA damage or early and late apoptotic cells could be 
detected for OA after 12 hours of exposure (Figure 3.5.a, 3.5.c). After 24 
hours the three highest concentrations of OA showed a significant increase 
in DNA fragmentation (Figure 3.5.b), firstly indicating genotoxic damage. 
However, a significant increase in late apoptosis (FITC+ / PI+) could also be 
detected for the three highest concentrations after 24 hours (Figure 3.5.d). 
DNA fragmentation is described in the literature as a late apoptotic event 
[38]. Therefore the co-occurrence of the two events suggested the DNA 
damage detected in the present study to be linked to late apoptosis rather 
than genotoxicity. Additionally early apoptotic cells (FITC+ / PI-) could be 
seen at concentrations of 33 ng/mL and 100 ng/mL, after 24 hours (Figure 
3.5.d). This demonstrated apoptotic processes to be involved to an extent in 
OA toxicity. As mentioned for Jurkat T cells, not all cells within one 
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population undergo apoptotic processes in the same time frame [37]. 
Supporting the above hypothesis are the results of the present study 
showing the change in the total cell numbers found for 12 hours and 24 
hours of exposure to OA. After 12 hours the cell number at 10 and 33 ng/mL 
had already decreased by approximately 30%, compared to the blank. After 
24 hours of exposure the cell numbers were below 40% for the three highest 
concentrations (Table 3.5.). The data in the current study indicated an 
apoptotic effect rather than a genotoxic effect of OA on HepG-2 cells. The 
loss in cell number due to the completion of the apoptotic process would tie 
in with the visual observations made during the initial stages of the assays. 
When performing the assays the exposure medium was transferred to 
Eppendorf tubes and centrifuged before the attached cells were actively 
detached using trypsin-EDTA. At both time points a substantial amount of 
floating cells could be seen in the exposure medium. Although these cells 
were added to the actively detached cells the total cell numbers were 
distinctly lower compared to the blank. 
The findings in the present study are supported by the limited literature 
available. In T lymphoma cells and Jurkat T cells OA has been demonstrated 
to induce apoptosis [39, 40]. For CaCo-2 the reports are more contradictory. 
Some studies found OA to increase the formation of micronuclei and cause 
DNA fragmentation in a dose and time dependent manner. The authors 
therefore concluded OA to be genotoxic [9, 34]. Others inferred OA to 
execute cell death via necrosis using the Damaged DNA Detection (3D) 
assay5 [29]. Another study found OA to induce DNA strand breaks in the 
COMET assay but also clear indications of apoptosis induction [34]. The 
findings reported for HepG-2 cells show OA to induce DNA lesions [29], 
strand breaks [22] and micronuclei [28]. However, observations are in favour 
of cell death [29] and nuclei fragmentation linked to apoptotic processes [2]. 
The involvement of apoptosis in OA toxicity has also been widely described 
as an effect in other cell lines such as human neuroplastoma cells (BE(2)-17, 
                                                          
5 The 3D assay quantifies DNA damage through nucleotide excision repair (NER) 
and base excision repair (BER) [29]. 
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TR14, NT2-N) human lung fibroblasts (NHLF) and rat/human hepatocytes 
[13, 24, 41, 42]. In general, studies have suggested that OA toxicity is cell 
line dependent. Rossini et al. [31] found differential activation of caspase 
isoforms in HeLa S3 and MCF-7 and concluded the apoptotic effect to be cell 
line dependent. A similar conclusion was drawn by Valdiglesias et al. [22, 
23], Souid-Mensi et al. [29] and Rubiolo et al. [30] for the genotoxic potential 
of OA. These findings are supported by other studies which show a direct 
effect on the DNA in BHK-21 and HESV cells [17] but not in CHO-K1 cells 
[27]. The findings in the present study support the hypothesis that the effect 
of OA depends on the cell line investigated. The effect on cell viability seems 
to be similar in Jurkat T cells and CaCo-2 cells; however a higher percentage 
of tail DNA in the COMET assay could be detected after 24 hours in Jurkat T 
cells. While the effect after 48 hours is visibly lower in Jurkat T cells again, 
the amount of DNA fragmentation in CaCo-2 cells has increased. The 
percentage of early apoptotic cells (FITC+ / PI-) is higher in Jurkat T cells 
after 24 hours and 48 hours of exposure compared to CaCo-2 cells. HepG-2 
cells are stated in the literature to be the most sensitive to OA in comparison 
to CaCo-2 cells, for example [22]. Neither the viability determined by the 
Trypan Blue Exclusion assay or the percentage of tail DNA as shown by the 
COMET assay seems to indicate this sensitivity in the study conducted here. 
However, genotoxic damage does not lead to a reduction in cell number, 
while cells that undergo the full apoptotic process are lost [36]. Data given by 
the Trypan Blue Exclusion assay indicated a severe loss of HepG-2 cells in 
the time course of 24 hours of exposure to OA. This coincides with early and 
late apoptotic data given by flow cytometer analysis. Additionally, the DNA 
fragmentation detected in the COMET assay coincided with late apoptotic 
cells (FITC+ / PI+) at 24 hours. All data taken together suggests that HepG-2 
cells might undergo apoptosis in a faster time course than Jurkat T cells and 
CaCo-2 cells. Sundquist et al. [37] stated that the induction and time line of 
apoptosis is very much dependent on cell line, exposure time and compound 
concentration. Exposure time and the concentrations of OA have been kept 
constant in the current study indicating a definite cell line dependency. 
Overall, the data given by the present study implied that the sensitivity of the 
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cell lines to OA are, in increasing order of sensitivity, CaCo-2 cells  Jurkat T 
cells → HepG-2 cells. 
 
Technically, no cells should stain FITC- / PI+ only. However, a small 
percentage could be detected for CaCo-2 cells at the two highest 
concentrations of OA after 48 hours and in HepG-2 cells after 12 hours. 
Additionally, FITC- / PI+ stained cells could be seen in HepG-2 cells at all 
concentrations (including the blank) after 24 hours, except 100 ng/mL. No 
FITC- / PI+ stained cells could be detected for Jurkat T cells. The FITC- / PI+ 
stained cells are most likely due to handling and preparation of cells 
(centrifugation, re-suspension) prior to flow cytometer analysis [43]. Only 
adherent cell lines seem to be affected, indicating the further possibility of 
damage due to cell detachment. 
 
Conclusion 
Data obtained in the present study suggests that OA is not per se genotoxic. 
Flow cytometer data gave positive results for early apoptotic cells in all three 
cell lines. DNA fragmentation is a late event in apoptosis. The detected DNA 
fragmentation in the COMET assay and late apoptotic cells given by flow 
cytometer analysis coincided well for all three cell lines at the concentrations 
and time points used. All data therefore supports the hypothesis that the 
detected DNA fragmentation is most likely based on apoptotic processes 
rather than direct genotoxicity. This is in agreement with other literature that 
showed apoptosis to be involved in the effects of OA on a variety of cell lines 
[23, 29-31]. The cell line dependency of OA toxicity proposed by other 
authors can be reinforced in the study conducted here. HepG-2 cells were 
the most sensitive, while CaCo-2 cells and Jurkat T cells were less sensitive. 
A clear differentiation between the latter two cell lines is not possible with the 
data presented in this study. 
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Chapter 4: Azaspiracid 
Introduction 
Azaspiracids (AZAs) are a group of lipophilic polyether marine biotoxins with 
a unique spiral ring assembly. They were first detected in mussels from 
Ireland in 1995 after consumers in the Netherlands showed symptoms of 
Diarrhoeic Shellfish Poisoning [1, 2]. However, DSP toxins were below the 
regulatory limits and the toxin was later identified as a novel marine biotoxin 
and named azaspiracid [2, 3]. Symptoms of acute AZA poisoning (AZP) 
occur within 3-18 hours after consumption of contaminated shellfish and 
included nausea, vomiting, diarrhoea and stomach cramps [2]. A full 
recovery of the clinical symptoms takes place within 2-5 days. The 
dinoflagellate Azadinum spinosum has recently been recognized as the 
primary producer of AZA1 and AZA2 [4, 5] and to date over twenty 
analogues have been identified. Most of these analogues have been either 
proven or suggested to be biotransformation products in shellfish [6-8] and 
together with the parent compounds can accumulate in shellfish. This might 
cause environmental problems throughout the food web. Human consumers 
are potentially at risk due to the increased presence of AZAs in shellfish 
meant for the market worldwide [9-13]. Additionally, closures of aquaculture 
and harvesting sites can impact the local economy [14].  
Toxicological studies of AZAs are limited due to the lack of availability of 
toxins and toxin standards. One of the first studies by Ito et al. [15] identified 
the gastrointestinal tract (GI) as the main target of AZA. AZA was extracted 
from mussels and administrated to mice at a single dose of 130 or 300 µg 
per kg body weight by gastric intubation. Mice were sacrificed after 30 
minutes, 1, 2, 3 and 4 hours. The study detected shortened villi in the small 
intestine, degeneration of cells in the large intestine, accumulation of fat 
droplets in the liver and necrotic lymphocytes in the thymus, spleen and 
Peyer´s patch. In a later study by the same group, an increased weight of 
several organs and an accumulation of large volumes of gas in the small 
intestine after chronic exposure to AZA were detected [15]. Mice were dosed 
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twice a week with 1 µg to 50 µg AZA per kg body weight, up to 40 times in 
145 days. Recovery was generally slow and some of the mice developed 
lung tumours [16]. A recent study by Aune et al. [17] confirmed the findings in 
the GI tract but was unable to show any further signs of toxicity. Besides 
diarrheic symptoms, neurological effects, spasms, respiratory difficulties, 
paralysis and death were observed in mice after intraperitoneal (i.p.) 
injections of mussel extract containing AZA [1-3]. Newer studies with 
neuronal networks and primary neuronal cultures showed an inhibitory effect 
on bioelectrical activity, a dose and time dependent cytotoxicity but only 
moderate effects on cytosolic calcium concentrations, F-actin and the 
cytoskeleton [18-20]. In general, molecular effects of AZAs in different 
cellular systems have been increasingly investigated over the last number of 
years, also due to the gradually higher availability of standards [21]. Existing 
data have shown AZAs to have a cytotoxic effect on various cell lines [22-
27]. Cell lines, such as human lymphocytes (Jurkat T cells), epithelial 
colorectal adenocarcinoma cells (CaCo-2) and breast cancer cells (MCF-7), 
showed a clear effect on the cytoskeleton, including a rounder structure and 
a reduction in the amount of pseudopodia, a structure that is involved in cell-
cell and cell-surface interactions [20, 23, 26]. Further studies support those 
findings by showing changes in the E-cadherin pool in epithelial cells [28] 
and reductions in the level of F-actin [29]. Additionally, AZAs have been 
shown to increase cellular levels of cAMP [29-31], modulate intracellular pH 
in lymphocytes [30, 32], modify calcium flux [30, 31, 33] and inhibit 
cholesterol biosynthesis [34]. Possible implications on heart functions have 
been investigated recently in vitro, showing a blockage of hERG channels 
[35] and in vivo, demonstrating a change in heart physiology of rats [36]. 
Exposure in the latter study occurred via single intravenous injection at 
concentrations of 11 µg and 55 µg per kg body weight.  However, the exact 
cellular targets and the mechanism(s) by which AZAs attain their effects are 
still unknown. Data on long term effects and/or carcinogenicity are limited to 
the study by Ito et al. [16] with the detection of lung tumours in mice and a 
study by Colman et al. [37] on Japanese medaka. The latter examined the 
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teratogenic effect of AZA1 and found effects on the health and development 
of finfish embryos as well as on their general hatching success. 
 
Due to the lack of information on genotoxicity the purpose of the present 
study was to investigate the possible DNA damaging effect of AZA1-3. AZA1 
and AZA2 are naturally occurring and regularly found in shellfish samples. 
AZA3 occurs in lower concentrations or is often absent [38]. However, 
different potencies of AZA1-3 have been detected in in vivo and in vitro 
studies and results suggested AZA3 to possibly have a greater effect than 
AZA1 and AZA2 [24, 39, 40]. The COMET assay was used to detect possible 
DNA damage. To determine any overt cytotoxicity and/or apoptotic effects of 
the three analogues, additional assays were included as described in 
previous chapters.  
 
Material & Methods 
Chemicals & Reagents 
Certified reference standards for azaspiracid1-3 were purchased from the 
NRC, Canada. All chemicals were obtained from Sigma-Aldrich, Ireland 
unless otherwise indicated. Annexin V and Annexin V detection kit, flow 
tubes and flow cytometer fluids were purchased from BD Bioscience, UK. 
Microscope slides and cover slips were ordered from Fisher Scientific, 
Ireland. All plastic ware was purchased from Sarstedt, Ireland. 
 
Cell culture 
Jurkat T cells (human T cell lymphoblast), CaCo-2 cells (human epithelial 
colorectal adenocarcinoma cells) and HepG-2 cells (human hepatocellular 
cells) were provided by the European Collection of Cell Cultures (ECACC, 
operated by Public Health England) and cultured as described in Chapter 2. 
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Cell exposure 
AZAs were supplied at stock concentrations of 1.47 µM for AZA1, 1.50 µM 
for AZA2 and 1.25 µM for AZA3 dissolved in methanol. Stock concentrations 
of 1 µM were prepared and kept in a freezer at -80°C. Working solutions 
were prepared freshly before use by serial dilution to keep the volume added 
to the well consistent.   
Cells were seeded in 6 well plates at a density of 2 x 105 cells/mL. Adherent 
cells were seeded the night before (to allow re-attachment) while non-
adherent cells were seeded 4 hours prior to exposure. All cell lines were 
exposed to a final concentration of 0.01 nM, 0.1 nM, 1 nMand 10 nM of 
AZA1-3. Blanks were included in each experiment, either containing 
methanol or being vehicle free. In contrast to previous chapters, the 
reduction in cell number for HepG-2 cells after 24 hours was less prominent. 
Therefore, no need was seen to shorten the exposure time to 12 hours. 
Exposure times for all cell lines, Jurkat T cells, CaCo-2 and HepG-2 cells, 
were 24 hours and 48 hours.  
 
Assay analysis 
The Trypan Blue Exclusion assay, COMET assay and flow cytometer 
analysis were performed as described in Chapter 2. All cell counts and 
sample analysis were performed in duplicate and a total of four independent 
experiments were performed for each analogue, cell line and exposure time. 
 
Statistical analysis 
Statistical analysis was carried out using IBM SPSS Statistics 20. Data were 
expressed as mean ± standard deviation (SD) of four independent 
experiments. Outliers were identified by box plots and where clearly related 
to an experimental error, removed. Differences between means were 
established using the non-parametric Kruskal-Wallis-Test with Mann-Whitney 
U test for pairwise comparison. Results were considered significantly 
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different with a p-value ≤ 0.05 (*), 0.01 (**) and 0.001 (***). Correlation 
between Trypan Blue Exclusion assay data and flow cytometer data (FITC- / 
PI- plus FITC+ / PI-) was analysed using the Spearman´s rank correlation in 
Graph Pad Prism 5. 
 
Results 
The effect of azaspiracid1-3 on Jurkat T cells. 
Jurkat T cells were exposed to different concentrations of AZA1-3 for 24 and 
48 hours. No significant differences (p ≤ 0.05) between the blank and vehicle 
blank could be detected at any stage. Therefore the vehicle blank is used as 
reference blank when presenting the findings of this study. A significant 
reduction in cell number could be seen for AZA1-3 at the two highest 
concentrations (1 nM p ≤ 0.01; 10 nM p ≤ 0.001) after 48 hours (Table 4.1.). 
Although not statistically significant (p ≥ 0.05) a pattern of substantial 
reduction in cell number could also be seen for AZA2 at the two highest 
concentrations after 24 hours and at 0.1 nM after 48 hours. A substantial 
reduction in cell number could also be seen for AZA3 at all concentrations. 
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Table 4.1. Cell number of Jurkat T cells, expressed as % of the blank, after 
treatment with four different concentrations of AZA1-3 for 24 hours and 48 hours. 
Results are the mean ± SD of 4 independent experiments and were considered 
significantly different with a p-value of p ≤ 0.05 (*), 0.01 (**) and 0.001 (***). 
Biotoxin Exposure  Blank 0.01 0.1 1 10 
  
Time 
   
nM 
 
nM 
 
nM 
 
nM 
 
 
AZA1 
 
24 hours 
 
100 
 
92 ± 10 
 
89 ± 8 
 
82 ± 8 
 
84 ± 18 
 
 
 48 hours 100 83 ± 15 83 ± 15 
 
61 ± 13 
(**) 
64 ± 7 
(**) 
 
 
AZA2 
 
24 hours 
 
100 
 
104 ± 9 
 
101 ± 25 
 
62 ± 9 
 
72 ± 21 
 
 
 48 hours 100 105 ± 11 52 ± 9 32 ± 5 
(**) 
33 ± 7 
(**) 
 
 
AZA3 
 
24 hours 
 
100 
 
70 ± 22 
 
72 ± 14 
 
 
63 ± 16 
 
 
64 ± 16 
 
 
 48 hours 100 92 ± 29 87 ± 10 32 ± 3 
(**) 
31 ± 6 
(***) 
 
 
 
A significant reduction in cell viability could be detected for AZA1 at 10 nM (p 
≤ 0.01) after 24 hours and at 0.1 nM (p ≤ 0.05), 1 nM (p ≤ 0.01) and 10 nM (p 
≤ 0.001) after 48 hours. A significant dose and time dependent decrease in 
cell viability could also be seen for AZA2 and AZA3 at the two highest 
concentrations at both time points (p ≤ 0.01, except 1 nM (AZA2), 24 h p ≤ 
0.05; 1 nM (AZA3) 48 h p ≤ 0.001). The percentage of viable cells after 48 
hours was considerably lower than after 24 hours of exposure to all three 
AZAs (Table 4.2.).  
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Table 4.2. Cell viability of Jurkat T cells after treatment with four different 
concentrations of AZA1-3 for 24 hours and 48 hours. Results are the mean ± SD of 
4 independent experiments and were considered significantly different with a p-
value of p ≤ 0.05 (*), 0.01 (**) and 0.001 (***). 
Biotoxin Exposure  Blank Blank  0.01 0.1 1 10 
  
Time 
   
Vehicle 
 
nM 
 
nM 
 
nM 
 
nM 
 
 
AZA1 
 
24 hours 
 
99 ± 1.2 
 
97 ± 1.8 
 
95 ± 4.5 
 
94 ± 4.7 
 
90 ± 4.0 
 
87 ± 2.2 
(**) 
 
 48 hours 87 ± 4.2 85 ± 6.7 73 ± 1.7 52 ± 9.3 
(*) 
32 ± 7.3 
(**) 
26 ± 8.1 
(***) 
 
 
AZA2 
 
24 hours 
 
97 ± 0.8 
 
97 ± 0.8 
 
98 ± 0.9 
 
96 ± 0.7 
 
90 ± 4.1 
(*) 
 
88 ± 2.3 
(**) 
 
 48 hours 98 ± 0.3  97 ± 1.4 96 ± 2.3 84 ± 11.6 61 ± 5.7 
(**) 
54 ± 7.6 
(**) 
 
 
AZA3 
 
24 hours 
 
95 ± 0.9 
 
95 ± 0.8 
 
94 ± 0.7 
 
96 ± 1.0 
 
85 ± 3.7 
(**) 
 
82 ± 6.0 
(**) 
 
 48 hours 95 ± 1.1 96 ± 0.9 93 ± 2.2 93 ± 3.5 33 ± 18.3 
(***) 
36 ± 15.6 
(**) 
 
 
 
AZA1-3 showed different levels of DNA fragmentation in the COMET assay. 
No significant increase (p ≥ 0.05) in DNA fragmentation could be detected for 
AZA1 after 24 hours (Figure 4.1.a ) or 48 hours (Figure 4.1.b), but the 
percentage of tail DNA at a concentration of 1 nM and 10 nM after 48 hours 
is fractionally higher than the blank. After 24 hours a significant increase (p ≤ 
0.05) in DNA fragmentation could be identified for AZA2 at 10 nM (Figure 
4.1.c), no significant change (p ≥ 0.05) could be seen at any concentration 
for AZA3 (Figure 4.1.e). Both, AZA2 (Figure 4.1.d) and AZA3 (Figure 4.1.f) 
however showed a significant increase (p ≤ 0.001) in the percentage of tail 
DNA at a concentration of 1 nM and 10 nM after 48 hours of exposure. The 
increase in DNA fragmentation was highest in AZA3.  
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Figure 4.1. The effect of AZA1-3 on DNA fragmentation in Jurkat T cells 
after 24 hours (a, c, e) and 48 hours (b, d, f) of exposure. The different 
concentrations are compared to the blank and significance is marked as * (p 
≤ 0.05), ** (p ≤ 0.01) and *** (p ≤ 0.001). Results presented are the mean ± 
SD of 4 independent experiments. 
 
Correlation between cell viability obtained by the Trypan Blue Exclusion 
assay and Flow cytometer analysis (FITC- / PI- plus FITC+ / PI-) gave 
AZA1 
AZA2 
AZA3 
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coefficients of r = 0.9 (p ≤ 0.05) for AZA1 and AZA2 at both time points. 
AZA3 gave coefficients of r = 0.4 (24 hours, ns) and 0.6 (48 hours, ns). A 
significant increase in FITC+ / PI- stained cells (early apoptosis) could be 
detected by flow cytometer analysis at the two highest concentrations of 
AZA1 after 24 hours (p ≤ 0.001). Although not statistically significant (p 
≥0.05), an increase at 0.1 nM can also be seen, which might be of biological 
relevance (Figure 4.2.a). After 48 hours of exposure a significant increase (p 
≤ 0.001) in FITC+ / PI- stained cells (early apoptosis) could be detected at all 
concentrations of AZA1, except 0.01 nM (Figure 4.2.b). Significant amounts 
of FITC+ / PI+ stained cells (late apoptosis/necrosis) could be identified at 
the two highest concentrations after 24 hours (p ≤ 0.001) and at the three 
highest concentrations (0.1 nM p ≤ 0.05, all others p ≤ 0.001) after 48 hours 
of exposure. The percentage of FITC+ / PI+ stained cells (late 
apoptosis/necrosis) is distinctively higher after 48 hours compared to 24 
hours, overall the increase agrees with the reduction in cell viability as 
observed with the Trypan Blue Exclusion assay. AZA2 showed a significant 
increase in FITC+ / PI- stained cells (early apoptosis) at the three highest 
concentrations (0.1 nM p ≤ 0.01, all others p ≤ 0.001) at both time points 
(Figure 4.2.c, 4.2.d). A significant amount of both FITC+ / PI+ stained cells 
(late apoptosis/necrosis) could be detected for 0.1 nM (p ≤ 0.05), 1 nM (p ≤ 
0.001) and 10 nM (p ≤ 0.001) after 24 hours and 1 nM (p ≤ 0.001) and 10 nM 
(p ≤ 0.001) after 48 hours. Similar to AZA1, the percentages are considerably 
higher after 48 hours, which also agrees with the higher reduction in cell 
viability after 48 hours and the increase in percentage of tail DNA as shown 
by the COMET assay. Analysis of AZA3 identified a significant increase in 
FITC+ / PI- stained cells (early apoptosis) for the two highest concentrations 
at both time points (all p ≤ 0.001, except 1 nM 48 h p ≤ 0.01), the values 
being higher at 24 hours (Figure 4.2.e, 4.2.f). FITC+ / PI+ stained cells (late 
apoptosis/necrosis) could also be detected in significant amounts at the two 
highest concentrations at both time points (24 h 1 nM p ≤ 0.01, 10 nM p 
≤0.05; 48 h p ≤ 0.001) Just as AZA1 and AZA2 the percentage of FITC+ / 
PI+ stained cells (late apoptosis/necrosis) after 48 hours of exposure to 
AZA3 is considerable higher than after 24 hours and agrees well with the 
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increase in DNA fragmentation detected in the COMET assay and the 
reduction in cell viability shown by the Trypan Blue Exclusion assay. 
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Figure 4.2. The effect of AZA1-3 on apoptosis/necrosis in Jurkat T cells after 
24 hours (a, c, e) and 48 hours (b, d, f) of exposure. The different 
concentrations are compared to the blank and significance is marked as * (p 
≤ 0.05), ** (p ≤ 0.01) and *** (p ≤ 0.001). For flow cytometer analysis 
significances are only marked for early apoptosis. Results presented are the 
mean ± SD of 4 independent experiments. 
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The effect of azaspiracid1-3 on CaCo-2 cells. 
CaCo-2 cells were exposed to different concentrations of AZA1-3 for 24 
hours and 48 hours. No significant or otherwise substantial reduction in cell 
number could be shown for CaCo-2 cells (Table 4.3.). 
 
Table 4.3. Cell number of CaCo-2 cells, expressed as % of the blank, after 
treatment with four different concentrations of AZA1-3 for 24 hours and 48 hours. 
Results are the mean ± SD of 4 independent experiments and were considered 
significantly different with a p-value of p ≤ 0.05 (*), 0.01 (**) and 0.001 (***). 
Biotoxin Exposure  Blank 0.01 0.1 1 10 
  
Time 
   
nM 
 
nM 
 
nM 
 
nM 
 
 
AZA1 
 
24 hours 
 
100 
 
81 ± 19 
 
84 ± 9 
 
87 ± 5 
 
92 ± 28 
 
 48 hours 100 96 ± 16 109 ± 20 
 
90 ± 19 
 
88 ± 21 
 
 
AZA2 
 
24 hours 
 
100 
 
100 ± 10 
 
95 ± 17 
 
95 ± 28 
 
 
99 ± 37 
 
 48 hours 100 96 ± 26 88 ± 8 86 ± 18 
 
94 ± 13 
 
 
AZA3 
 
24 hours 
 
100 
 
108 ± 41 
 
97 ± 22 
 
 
97 ± 15 
 
 
93 ± 10 
 
 48 hours 100 121 ± 69 107 ± 39 91 ± 24 
 
85 ± 12 
 
 
 
A significant decrease in cell viability could be identified for AZA1-3 at 1 nM 
and 10 nM at both time points (1 nM all p ≤ 0.01, except AZA3 24 h p ≤ 0.05; 
10 nM AZA1 24 h p ≤ 0.05 48 h p ≤ 0.01, AZA2 and AZA3 p ≤ 0.001) (Table 
4.4.). The percentages for viable cells at 100 nM after 48 hours are 
considerably lower than after 24 hours.  
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Table 4.4. Cell viability of CaCo-2 cells after treatment with AZA1-3 for 24 hours 
and 48 hours. Results are the mean ± SD of 4 independent experiments and were 
considered significantly different with a p-value of p ≤ 0.05 (*), 0.01 (**) and 0.001 
(***). 
Biotoxin Exposure  Blank Blank  0.01 0.1 1 10 
  
Time 
   
Vehicle 
 
nM 
 
nM 
 
nM 
 
nM 
 
 
AZA1 
 
24 hours 
 
98 ± 0.5 
 
98 ± 0.6 
 
97 ± 1.2 
 
97 ± 0.9 
 
92 ± 2.1  
(**) 
 
91 ± 1.8 
(*) 
 
 48 hours 97 ± 1.1 97 ± 1.3 95 ± 2.4 96 ± 1.8 82 ± 2.9 
(**) 
 
77 ± 4.6 
(**) 
 
AZA2 
 
24 hours 
 
97 ± 0.6 
 
98 ± 0.9 
 
96 ± 1.5 
 
97 ± 1.5 
 
89 ± 2.6 
(**) 
 
85 ± 2.6 
(***) 
 
 48 hours 98 ± 0.6 98 ± 0.9 98 ± 0.7 97 ± 1.0 80 ± 6.4 
(**) 
67 ± 1.1 
(***) 
 
 
AZA3 
 
24 hours 
 
98 ± 1.2 
 
98 ± 0.4 
 
98 ± 0.6 
 
97 ± 0.8 
 
92 ± 3.7 
(*) 
 
86 ± 7.2 
(***) 
 
 48 hours 97 ± 2.1 98 ± 0.7 96 ± 1.4 95 ± 0.6 82 ± 13.6 
(**) 
71 ± 11.6 
(***) 
 
 
 
Different effects on DNA fragmentation could be detected in CaCo-2 cells by 
the COMET assay. Exposure to AZA1 showed a significant increase in DNA 
fragmentation at concentrations of 0.1 nM (p ≤ 0.05), 1 nM (p ≤ 0.01) and 10 
nM (p ≤ 0.001) after 24 hours (Figure 4.3.a) and at the two highest 
concentrations (1 nM p ≤ 0.01, 10 nM p ≤ 0.001) after 48 hours (Figure 
4.3.b). The increase in tail DNA is higher after 48 hours than after 24 hours, 
indicating not only a concentration, but also a time dependent effect. In 
contrast to AZA1, exposure to AZA2 caused no significant increase (p ≥ 
0.05) in DNA fragmentation after 24 hours (Figure 4.3.c) and only at a 
concentration of 10 nM (p ≤ 0.01) after 48 hours (Figure 4.3.d). The pattern 
of DNA fragmentation for AZA3 is similar to one observed for AZA2. No 
significant change (p ≥ 0.05) in the percentage of tail DNA could be seen 
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after 24 hours of exposure to AZA3 (Figure 4.3.e) but a significant increase 
in DNA fragmentation could be detected after 48 hours at the two highest 
concentrations (1 nM p ≤ 0.05, 10 nM p ≤ 0.001) (Figure 4.3.f). 
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Figure 4.3. The effect of AZA1-3 on DNA fragmentation in CaCo-2 cells 
after 24 hours (a, c, e) and 48 hours (b, d, f) of exposure. The different 
concentrations are compared to the blank and significance is marked as * (p 
≤ 0.05), ** (p ≤ 0.01) and *** (p ≤ 0.001). Results presented are the mean ± 
SD of 4 independent experiments. 
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Comparing the viabilities obtained by the Trypan Blue Exclusion assay and 
flow cytometer analysis (sum of FITC- / PI- and FITC+ / PI- stained cells), 
correlation coefficients of r = 0.5 (24 hours, ns) and r = 0.9 (48 hours, p ≤ 
0.05) for AZA1, r = 0.7 (24 hours, ns) and r = 0.8 (48 hours, ns) for AZA2 and 
r = 0.9 (24 hours, p ≤ 0.05) and r = 1 (48 hours, p ≤ 0.01) for AZA3 could be 
calculated. Flow cytometer analysis showed a significant increase (p ≤ 
0.001) in FITC+ / PI- stained cells (early apoptosis) for AZA1 at a 
concentration of 1 nM after 24 hours (Figure 4.4.a), a significant increase for 
FITC+ / PI+ stained cells (late apoptosis/necrosis) could be shown at both 
time points for the two highest concentrations (p ≤ 0.001, except 1 nM, 24 h 
p ≤ 0.01) (Figure 4.4.a, 4.4.b). The considerably higher amount of FITC+ / 
PI+ stained cells (late apoptosis/ necrosis) after 48 hours compared to 24 
hours coincides with the increase in tail DNA as well as the stronger effect of 
AZA1 on cell viability after 48 hours. FITC- / PI+ stained cells could be 
identified for 10 nM after 48 hours. No significant increase (p ≥ 0.05) in 
FITC+ / PI- stained cells (early apoptosis) could be detected for AZA2. In 
contrast to AZA1 and AZA3, the blank and the two lowest concentrations at 
48 hours show a higher (not statistically significant, p ≥ 0.05) amount of 
FITC+ / PI- stained cells (early apoptosis). A significant increase in FITC+ / 
PI+ stained cells (late apoptosis/necrosis) could be seen at concentrations of 
1 nM (p ≤ 0.01) and 10 nM (p ≤ 0.001) at both time points (Figure 4.4.c, 
4.4.d). Similar to AZA1, the percentage of FITC+ / PI+ stained cells (late 
apoptosis/necrosis) after 48 hours is considerably higher than after 24 hours 
and agrees with the decrease in cell viability detected by the Trypan Blue 
Exclusion assay. AZA3 showed a significant increase in FITC+ / PI- stained 
cells (early apoptosis) at 1 nM (p ≤ 0.05) and 10 nM (p ≤ 0.01) after 24 hours 
(Figure 4.4.e), no significant increase at any concentration could be detected 
after 48 hours (Figure 4.4.f). A significant increase in FITC+ / PI+ stained 
cells (late apoptosis/necrosis) could be seen for 1 nM (p ≤ 0.05) and 10 nM 
(p ≤ 0.001) after 24 hours of exposure and for 10 nM (p ≤ 0.01) after 48 
hours. Similar to AZA1 and AZA2 this increase correlates well with the 
viabilities detected by the Trypan Blue Exclusion assay at both time points 
and with the increase in tail DNA detected by the COMET assay at 48 hours 
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of exposure. Although not significant (p ≥ 0.05), an increase in FITC+ / PI+ 
stained cells (late apoptosis/necrosis) could also be seen at 1 nM after 48 
hours, which might be of biological relevance.  
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Figure 4.4. The effect of AZA1-3 on apoptosis/necrosis in CaCo-2 cells after 
24 hours (a, c, e) and 48 hours (b, d, f) of exposure. The different 
concentrations are compared to the blank and significance is marked as * (p 
≤ 0.05), ** (p ≤ 0.01) and *** (p ≤ 0.001). For flow cytometer analysis 
significances are only marked for early apoptosis. Results presented are the 
mean ± SD of 4 independent experiments. 
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The effect of azaspiracid1-3 on HepG-2 cells. 
HepG-2 cells were exposed to different concentrations of AZA1-3 for 24 
hours and 48 hours. Significant reductions in cell number were detected for 
AZA1 at the three highest concentrations (0.1 and 1 nM p ≤ 0.05, 10 nM p ≤ 
0.001) after 24 hours and at the two highest concentrations after 48 hours (p 
≤ 0.001). AZA2 only caused a significant reduction in cell number at 1 nM (p 
≤ 0.05) and 10 nM (p ≤0.01) and AZA3 at the highest concentration (p ≤ 
0.05) at 48 hours (Table 4.5.). However various substantial but not 
statistically significant decreases in cell numbers could be seen at 0.01 nM 
(24 hours) for AZA1, 10 nM and possibly 1 nM (24 hours) for AZA2 and 10 
nM (24 hours) and 1 nM (48 hours) for AZA3. 
 
Table 4.5. Cell number of HepG-2 cells, expressed as % of the blank, after 
treatment with four different concentrations of AZA1-3 for 24 hours and 48 hours. 
Results are the mean ± SD of 4 independent experiments and were considered 
significantly different with a p-value of p ≤ 0.05 (*), 0.01 (**) and 0.001 (***). 
Biotoxin Exposure  Blank 0.01 0.1 1 10 
  
Time 
   
nM 
 
nM 
 
nM 
 
nM 
 
 
AZA1 
 
24 hours 
 
100 
 
79 ± 15 
 
75 ± 18 
(*) 
 
78 ± 16 
(*) 
 
65 ± 14 
(***) 
 
 48 hours 100 88 ± 13 84 ± 5 
 
28 ± 5 
(**) 
29 ± 10 
(***) 
 
 
AZA2 
 
24 hours 
 
100 
 
93 ± 19 
 
98 ± 44 
 
85 ± 10 
 
72 ± 12 
 
 
 48 hours 100 96 ± 23 83 ± 21 30 ± 15 
(*) 
21 ± 11 
(**) 
 
 
AZA3 
 
24 hours 
 
100 
 
118 ± 25 
 
89 ± 10 
 
 
92 ± 16 
 
 
71 ± 31 
 
 
 48 hours 100 95 ± 16 105 ± 24 42 ± 25 
 
28 ± 8 
(*) 
 
 
Chapter 4: Azaspiracid 
114 
 
A significant reduction in cell viability could be detected by the Trypan Blue 
Exclusion assay at 1 nM and 10 nM for AZA1-3 at both time points (1 nM 
AZA1, AZA2 48 h p ≤ 0.05, AZA2 24h, AZA3 p ≤ 0.01; 10 nM AZA1 24 h p ≤ 
0.05, AZA2/AZA3 48 h, AZA3 24 h p ≤ 0.01, AZA2 24 h / AZA3 48 h p ≤ 
0.001) (Table 4.6.). The cell viabilities are lower at the two highest 
concentrations after 48 hours compared to 24 hours, indicating AZAs to have 
a dose and time dependent effect.  
 
Table 4.6. Cell viability of HepG-2 cells after treatment with AZA1-3 for 24 hours 
and 48 hours. Results are the mean ± SD of 4 independent experiments and were 
considered significantly different with a p-value of p ≤ 0.05 (*), 0.01 (**) and 0.001 
(***). 
Biotoxin Exposure  Blank Blank  0.01 0.1 1 10 
  
Time 
   
Vehicle 
 
nM 
 
nM 
 
nM 
 
nM 
 
 
AZA1 
 
24 hours 
 
98 ± 0.7 
 
98 ± 0.6 
 
98 ± 0.7 
 
98 ± 0.6 
 
89 ± 3.7 
(*) 
 
88 ± 5.1 
(*) 
 
 48 hours 98 ± 0.9 97 ± 1.8 98 ± 1.5 97 ± 1.7 52 ± 17.3 
(*) 
23 ± 6.4 
(**) 
 
 
AZA2 
 
24 hours 
 
97 ± 2.4 
 
99 ± 0.3 
 
97 ± 1.6 
 
96 ± 1.4 
 
86 ± 2.9 
(**) 
 
84 ± 2.2 
(***) 
 
 48 hours 97± 1.0 96 ± 2.4 97 ± 1.8 94 ± 3.2 74 ± 6.7 
(*) 
44 ± 14.0 
(**) 
 
 
AZA3 
 
24 hours 
 
96 ± 1.5 
 
96 ± 1.5 
 
96 ± 1.7 
 
95 ± 2.1 
 
82 ± 5.5 
(**) 
 
78 ± 1.8 
(**) 
 
 48 hours 95 ± 1.8 95 ± 1.4 93 ± 0.7 94 ± 1.1 74 ± 6.2 
(**) 
19 ± 11.9 
(***) 
 
 
 
Different effects of AZA1-3 on DNA fragmentation could be shown in the 
COMET assay. A small but significant change in the percentage of tail DNA 
could be detected for AZA1 at a concentration of 0.1 nM (p ≤ 0.05) after 24 
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hours (Figure 4.5.a). The value for this DNA fragmentation is lower than the 
blank, so this change might be of no biological relevance. After 48 hours of 
exposure a significant increase (p ≤ 0.001) in DNA fragmentation could be 
seen at the two highest concentrations (Figure 4.5.b). In contrast to AZA1, 
AZA2 caused a significant increase in DNA fragmentation at concentrations 
of 0.1 nM (p ≤ 0.05), 1 nM (p ≤ 0.001) and 10 nM (p ≤ 0.001) after 24 hours 
(Figure 4.5.c) and at 1 nM (p ≤ 0.001) and 10 nM (p ≤ 0.001) after 48 hours 
(Figure 4.5.d). The values after 48 hours are clearly higher than after 24 
hours but are in a similar range as for AZA1. Exposure to AZA3 identified a 
significant increase in the percentage of tail DNA at the two highest 
concentrations (1 nM p ≤ 0.01; 10 nM p ≤ 0.001) after 24 hours (Figure 
4.5.e) and for 0.1 nM (p ≤ 0.05) and 10 nM (p ≤ 0.001) after 48 hours (Figure 
4.5.f). The value for 0.1 nM is lower than the blank and probably of no 
biological relevance. Just as AZA1 and AZA2 the actual increase at 10 nM of 
AZA3 is higher after 48 hours than after 24 hours. Although not significant (p 
≥ 0.05) the DNA fragmentation at 1 µM after 48 hours of exposure is higher 
than the blank and might be of biological relevance nevertheless. 
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Figure 4.5. The effect of AZA1-3 on DNA fragmentation in HepG-2 cells 
after 24 hours (a, c, e) and 48 hours (b, d, f) of exposure. The different 
concentrations are compared to the blank and significance is marked as * (p 
≤ 0.05), ** (p ≤ 0.01) and *** (p ≤ 0.001). Results presented are the mean ± 
SD of 4 independent experiments. 
 
Correlation between data obtained by the Trypan Blue Exclusion assay and 
Flow cytometer analysis (sum of FITC- / PI- and FITC+ / PI- cells) gave 
correlation coefficients of r = 0.2 (24 hours, ns) and r = 0.9 (48 hours, p ≤ 
AZA1 
AZA2 
AZA3 
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0.05) for AZA1, r = 0.8 (24 hours, ns) and r = 0.6 (48 hours, ns) for AZA2 and 
r = 1 (24 hours, p ≤ 0.01) and r = 0.9 (48 hours, p ≤ 0.05) for AZA3. No 
significant increase (p ≥ 0.05) in FITC+ / PI- stained cells (early apoptosis) 
could be detected at any concentration or time point after exposure to AZA1. 
A significant increase in FITC+ / PI+ stained cells (late apoptosis/necrosis) 
however could be seen at the two highest concentrations (1 nM p ≤ 0.01; 10 
nM p ≤ 0.001) at both time points (Figure 4.6.a, 4.6.b). The percentage after 
48 hours is higher than after 24 hours. This increase in FITC+ / PI+ stained 
cells (late apoptosis/necrosis) correlates with the decrease in cell viability as 
detected by the Trypan Blue Exclusion assay for both time points and 
coincides with the increase in DNA fragmentation after 48 hours. FITC- / PI+ 
stained cells could be identified for 1 nM after 48 hours. In contrast to AZA1, 
AZA2 showed a significant change in FITC+ / PI- stained cells (early 
apoptosis) at concentrations of 1 nM (p ≤ 0.001) and 10 nM (p ≤ 0.001) after 
24 hours (Figure 4.6.c) and a significant increase (1 nM p ≤ 0.01; 10 nM p ≤ 
0.001)  after 48 hours (Figure 4.6.d). The percentage of FITC+ / PI+ stained 
cells (late apoptosis/necrosis) was significantly increased at the two highest 
concentrations at both time points (all p ≤ 0.001, except 1 nM, 48 h p ≤ 0.01), 
the values are higher after 48 hours. Similar to AZA1 this increase in FITC+ / 
PI+ stained cells (late apoptosis/necrosis) after exposure to AZA2 coincides 
with the decrease in cell viability and the increase in DNA fragmentation. 
AZA3 only shows a significant increase in FITC+ /PI- stained cells (early 
apoptosis) at 1 nM (p ≤ 0.001) and 10 nM (p ≤ 0.001) after 48 hours (Figure 
4.6.f). A significant increase in FITC+ / PI+ stained cells (late 
apoptosis/necrosis) could be identified for the same concentrations at both 
time points (1 nM, 24 h p ≤ 0.05, 48 h p ≤ 0.01; 10 nM p ≤ 0.001) (Figure 
4.6.e, 4.6.f). This coincides with an increase in DNA fragmentation and a 
decrease in cell viability, similar to what has been shown for AZA1 and 
AZA2.  
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Figure 4.6. The effect of AZA1-3 on apoptosis/necrosis in HepG-2 cells after 
24 hours (a, c, e) and 48 hours (b, d, f) of exposure. The different 
concentrations are compared to the blank and significance is marked as * (p 
≤ 0.05), ** (p ≤ 0.01) and *** (p ≤ 0.001). For flow cytometer analysis 
significances are only marked for early apoptosis. Results presented are the 
mean ± SD of 4 independent experiments. 
 
 
AZA1 
AZA2 
AZA3 
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Discussion 
Azaspiracids (AZAs) are a group of polyether marine biotoxins with a unique 
spiral ring assembly. Because of their lipophilic character they are able to 
accumulate in shellfish and pose a health risk to consumers as well as a risk 
to the environment and the shellfish industry [1, 2]. Limited data are available 
on their acute toxicity and possible long term effects; no data are available 
on genotoxicity. The main focus of the present study was to identify the 
possible genotoxic effect of AZA1-3 using the COMET assay. The Trypan 
Blue Exclusion assay and flow cytometer analysis were included in the 
present study to determine the possible involvement of overt cytotoxicity and 
apoptotic processes in the observed DNA fragmentation. All assays were 
performed on Jurkat T cells, CaCo-2 cells and HepG-2 cells. 
Attempts were made to ensure that the mixing of cells and the sampling of 
aliquots for the Trypan Blue Exclusion assay was as constant as possible. 
However, slight variations are likely. While this would not affect the cell 
viability per se it might well account for higher standard deviations (SD) in 
cell numbers.  
Technically, no cells should stain FITC- / PI+ only. However, a small 
percentage could be detected for AZA1 at a concentration of 10 nM (48 
hours) in CaCo-2 cells and 1 nM (48 hours) in HepG-2 cells. Most likely this 
is due to handling and preparation of cells (centrifugation, re-suspension) 
prior to flow cytometer analysis and this observation is considered of no 
biological relevance [41]. The same can be expected for the comparison 
between viability data obtained by the Trypan Blue Exclusion assay and flow 
cytometer analysis. Correlation coefficients in most cases ranged from r = 
0.7-0.9, for all three cell lines and time points. Although some of the 
correlations are not statistically significant, they are most likely of biological 
relevance. The absence of statistical power for some coefficients could be 
due to the sample number. The few exceptions with low coefficients, for 
example r = 0.2 are probably a result of the above mentioned handling and 
preparation processes. Cell samples for the Trypan Blue Exclusion assay are 
taken straight after detachment, while viability data by flow cytometer 
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analysis undergo two further washing and re-suspension processes. In some 
cases the substantial loss in cell number might also contribute to the lower 
correlation coefficients. 
The limited data available on AZAs and especially with focus on AZA1-3 
suggests that these analogues have different potencies and may have 
multiple molecular targets [23, 24, 29, 42]. Twiner et al. [24] found AZA1 to 
have an effect on the pseudopodia number in Jurkat T cells, while AZA2 and 
AZA3 showed no effect. Other studies found different effects of AZA1-5 on 
pH and calcium flux in Jurkat T cells and freshly isolated human 
lymphocytes. The authors proposed a structure-activity relationship involved 
in the modulation and coupling of pH and Ca2+ [43-46]. In the present study, 
Jurkat T cells showed a time and dose dependent effect of all three AZAs. 
However, comparing the three different AZAs with each other, AZA1 seems 
to have the earliest and possibly most potent effect on cell viability. Not only 
do results show the lowest percentage of viable cells after 48 hours, but also 
that a lower concentration is needed after 48 hours to cause a significant 
reduction in cell viability. AZA2 has the least apparent effect of the three 
AZAs at the concentrations and time points tested. These observations are in 
slight contradiction with a study by Twiner et al. [24] in which AZA2 and 
AZA3 showed a stronger effect on cell viability than AZA1. However, a 
previous study by the same researchers, only on AZA1, detected lower 
viabilities at the same concentrations which are more in line with the findings 
here. A possible explanation for the discrepancy between the present study 
and the above mentioned study by Twiner et al. [24] could be the different 
methods of detection. Overall, data acquired in the present study are in 
agreement with published literature. DNA fragmentation in Jurkat T cells, as 
determined by the COMET assay was mainly detectable after 48 hours. 
AZA3 and AZA2 showed significant increases in percentage of tail DNA at 
the two highest concentrations, with AZA3 having the higher values. In 
contrast to the above mentioned cytotoxicity, AZA3 showed the strongest 
effect on DNA fragmentation, followed by AZA2. AZA1 showed no significant 
effect. These data would indicate AZA2 and AZA3 to have a genotoxic effect 
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on Jurkat T cells. However, one criterion for direct genotoxicity is a 
consistent cell number [47]. In the current study, all three AZAs induced 
statistically significant and/or substantial cell losses. This suggests apoptotic 
processes rather than direct genotoxicity to have taken place. This is 
supported by flow cytometer results for AZA1-3. After 24 hours of exposure 
all three analogues showed early apoptotic cells at the two highest 
concentrations, as well as for 0.1 nM for AZA2 and not significant but still 
noticeable for AZA1. The significant increase of FITC+ / PI+ stained cells 
(late apoptosis/necrosis) in combination with significant amounts of early 
apoptotic cells after 48 hours of exposure suggest a shift from early 
apoptosis to late apoptosis within the time points tested for all three 
analogues. In contrast to AZA1 and AZA2, AZA3 only showed negligible 
amounts of viable cells after 48 hours of exposure for the two highest 
concentrations. As for the data presented for DNA fragmentation, AZA3 
seems to have the most prominent effect on Jurkat T cells. The data 
presented in the present study suggest the above described DNA 
fragmentation, as detected by the COMET assay, to be the result of 
cytotoxicity and/or apoptotic/necrotic processes rather than direct 
genotoxicity. The fact that DNA fragmentation has been described in the 
literature as a late apoptotic event [48, 49] and a recent study by Twiner et 
al. [42] detecting DNA laddering, a late apoptotic hallmark, after treatment of 
Jurkat T cells with AZA1-3 for 48 hours, support this conclusion. In contrast, 
a report by Hess et al. [31] mentioned the inability to detect caspase-3, 
another marker for apoptotic processes, in Jurkat T cells after exposure to 
AZA1. However, no further information was given in the report on exposure 
time and concentration, making a direct comparison difficult. 
CaCo-2 cells showed a significant time and dose dependent reduction in cell 
viability for all three analogues. Viabilities identified for CaCo-2 cells by 
Twiner et al. [42] and Sérandour et al. [27] for AZA1 are well in agreement 
with the ones found in the study conducted here. No data are available in the 
literature for the other two analogues. Overall, AZA2 seems to be slightly 
more potent. The data obtained by the COMET assay on the other hand 
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showed a dose and time dependent effect of AZA1, while AZA2 and AZA3 
seem to have the least or possibly a slower effect on DNA fragmentation. 
AZA2 only showed a significant increase in percentage tail DNA after 48 
hours at 10 nM and AZA3 at 48 hours at 1 nM and 10 nM. However, the 
values are clearly lower than for AZA1. No reduction in cell number below 
80% could be seen for all AZAs at any concentration or time point. This 
would firstly indicate a genotoxic effect of AZAs on CaCo-2 cells. Flow 
cytometer analysis identified early apoptotic cells only for AZA1 at 1 nM and 
for AZA3 at 1 nM and 10 nM after 24 hours; no early apoptosis was detected 
after 48 hours for any of the three analogues. However, AZA1-3 at the two 
highest concentrations showed a distinct increase in late apoptotic/necrotic 
cells after 24 hours and 48 hours of exposure, although not statistically 
significant. The values are in all cases higher after 48 hours, indicating a time 
dependent effect. In contrast to cell viability and DNA fragmentation, no clear 
difference between the three analogues could be observed for flow 
cytometer data. The previous mentioned study by Twiner et al. [42] also 
detected DNA laddering as a marker of late apoptotic events in CaCo-2 cells 
after exposure to AZA1. In the present study, the DNA fragmentation is in 
agreement with the detection of late apoptotic/necrotic cells but lower than 
flow cytometer analysis would suggest. The lack of significant amounts of 
early apoptotic cells and the good correlation of DNA fragmentation with the 
moderate reduction in cell viability raises the question if the effect of AZA1-3 
on CaCo-2 is based on cytotoxic or necrotic rather than apoptotic processes 
or genotoxicity.  
In contrast to previous chapters, initial experiments showed that the 
reduction in cell number for HepG-2 cells after 24 hours was less prominent 
than observed with OA and the positive controls (Chapter 2 and 3). 
Therefore, there was no need to shorten the exposure time to 12 hours for 
AZAs. This indicates a slower time course of AZA toxicity compared to the 
positive controls and OA in HepG-2 cells. HepG-2 cells showed a dose and 
time dependent reduction in cell viability for all three AZAs tested, AZA1 and 
AZA3 showing a more potent effect than AZA2. Cytotoxicity data in the 
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literature are only available for AZA1 and results presented in the study by 
Sérandour et al. [27] are well in agreement with data found here. A time 
dependent effect can also be seen for the percentage of tail DNA, detected 
by the COMET assay. In contrast to AZA1, AZA2 and AZA3 already showed 
significant amounts of DNA fragmentation after 24 hours of exposure. 
However, the percentages of tail DNA are similar for all three analogues. The 
DNA fragmentation for AZA1 and AZA2 after 48 hours is similar, higher 
values were detectable for AZA3. The significant differences for AZA1 at 0.1 
nM after 24 hours and AZA3 after 48 hours are lower than the blank and are 
almost certainly not of biological relevance. The moderate DNA damage 
given by the COMET assay alone would suggest a genotoxic effect of AZA1-
3 on HepG-2 cells. Based on the same consideration as described before, 
the substantial reduction in cell number detected in the present study 
indicates apoptotic processes to have taken place. This is supported by flow 
cytometer analysis. A significant increase in early apoptotic cells could be 
detected for AZA2 and AZA3 after 48 hours at the two highest 
concentrations. Late apoptotic/necrotic cells could be shown for AZA1-3 at 
the two highest concentrations for both time points. In all cases the values 
after 48 hours of exposure are higher, indicating a time dependent effect. In 
contrast to data on cell viability, AZA2 caused stronger/earlier effects in the 
COMET assay and flow cytometer than AZA1, and overall AZA3 seems to be 
the most potent AZA. All data taken together suggest a cytotoxic or 
apoptotic/necrotic effect of AZAs on HepG-2 cells rather than direct 
genotoxicity. 
The, at times seemingly, contradicting results of AZAs among the literature 
available, could be based on differences in the assays, exposure times and 
concentrations used. Twiner et al. [24] proposed multiple molecular targets 
for AZAs. Roman et al. [30] found differences in the effect of AZA2 and AZA3 
on intracellular [Ca2+] and pH. The authors suggested a structure-activity 
relationship as possible explanation. AZA4, which has not been investigated 
in the present study, showed an opposite effect on cytosolic calcium levels 
than AZA1-3 [33]. Satake et al. [1] and Ofuji et al. [40] detected different 
Chapter 4: Azaspiracid 
124 
 
potencies of AZA1-3 in vivo, which have been confirmed in other studies in 
vitro in lymphocytes [24] and neocortical neurons [39]. The order of potency 
varied among the cell lines, yet AZA1 was in all cases the least potent one of 
the three analogues. Similar to the study by Cao et al. [39] on neurons, AZA3 
has an earlier and possibly more potent effect on Jurkat T cells in the present 
study. This is in contradiction to the study by Twiner et al. [24] which found 
AZA2 to be the most potent analogue in Jurkat T cells. Possible explanations 
are the different approaches. In the current study, all three assays were 
taken into account while the potency by Twiner et al. [24] is established by 
cytotoxicity data alone. Also, the methods to determine cell viability in both 
studies are different. A clear difference in potency of AZA1 and AZA2 in 
Jurkat T cells and AZA2 and AZA3 in HepG-2 cells as well as all three 
analogues in CaCo-2 cells cannot be suggested in the present study with the 
data available. A study by Vilarino et al. [50] found AZA1 and AZA2 to have 
similar effects on morphological changes in Be(2)-M13 cells. TEFs for AZAs 
are given in the EFSA report [51], the potency order relative to AZA1 is as 
follows, AZA2 (TEF = 1.8) › AZA3 (TEF = 1.4) › AZA1 (TEF = 1). These TEFs 
are based on in vivo studies on acute toxicity in mice after i.p. administration; 
these values were adopted by the EFSA panel as an interim measure to 
provide an estimate of AZAs toxicity and are not considered to be very robust 
due to the limited data available. Data in the present study do not indicate 
such clear differences between the three analogues. Direct comparison is 
difficult because of the differences in models (in vivo vs in vitro) and 
endpoints used. The cell lines used in the current study are representing 
main target organs of AZA toxicity. Limited to no data are available on direct 
comparison of different cell lines; data available are mostly based on one 
analogue. Twiner et al. [42] found Jurkat T cells to be the most sensitive to 
AZA1, followed by CaCo-2 cells and neuroblastoma cells (BE(2)-M17. 
Sérandour et al. [27] identified HepG-2 cells and Neuro2a cells to be 
significantly more sensitive to AZA1 than CaCo-2 cells in an inter- and intra-
laboratory study. Another study by Ronzitti et al. [28] showed MCF-7 cells to 
be affected by AZA1 exposure, while no effect on CaCo-2 viability was 
detectable. All these studies tie in with the results found here. Jurkat T cells 
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appear the most sensitive to AZAs exposure, followed by HepG-2 cells and 
the least sensitive being CaCo-2 cells. This descending sensitivity seems to 
be the same among all three analogues tested. However, within one cell line 
there seem to be different potencies among AZA1-3.  
Although the gastrointestinal tract, lymphatic system and liver are main 
targets of AZAs [15] it is still unknown how the observed in vivo and in vitro 
effects are linked. The disruption of the intestinal barrier is suggested to be a 
result of morphological changes and alterations in the cytoskeleton, mainly 
caused by changes in the F-actin levels and E-cadherin system [23, 25, 28, 
29, 31]. Experiments with CaCo-2 cells showed severe cell detachment after 
AZAs exposure (50 nM) [20] and a decrease of TEER6 in CaCo-2 
monolayers [31]. In contrast, no substantial reduction in cell number could be 
seen in the present study. The most likely explanation for this discrepancy is 
the lower concentration (max. 10 nM) used, over the same time course. Little 
is known on the effect of AZAs on the liver, Ito et al. [15, 16, 52] reported 
increased organ weight, accumulation of fat droplets and sporadic 
occurrence of necrosis. T and B lymphocytes have been reported to undergo 
necrosis in the thymus, spleen and Peyers patch [15]. AZAs have also been 
hypothesised to be tumor initiators/promoters due to the in vivo detection of 
lung tumours in the MBA [16, 52]. Experiments conducted in the current 
study attempted to increase the general knowledge of AZA toxicity, focusing 
on genotoxic effects and the potential to cause possible long term effects. 
Data presented suggest an apoptotic/necrotic effect rather than genotoxicity 
per se, in all three cell lines and analogues tested. Literature on apoptosis 
induction after AZA exposure is limited and partly contradictory. Román et al. 
[29] found no induction of apoptosis in BE(2)-M17 after AZA1 exposure, 
neither did Hess et al. [31] find an increase in caspase-3 in Jurkat T cells. 
HeLa cells seemed to neither show cytotoxic nor apoptotic effects after 
exposure to AZA2 [53]. On the other hand, studies by various other groups 
showed AZAs to have an apoptotic effect. Vilarino et al. [26] detected the 
                                                          
6 The transepithelial electrical resistance (TEER) is an indicator of barrier integrity. It is based on ion 
flux across the paracellular pathway resulting in an electrical resistance [31]. 
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induction of caspase-3 in neuroplastoma cells after AZA1 exposure, but 
concluded that this activation is not responsible for the disarrangement of the 
cytoskeleton. Twiner et al. [42] identified many steps, including activation of 
various caspases involved in apoptotic cell death in Jurkat T cells after 
exposure to AZA1. Cao et al. [39] confirmed the studies by Vilarino et al. [26] 
described above, finding AZA1 to produce neuronal apoptosis. However, the 
authors also described induced neurotoxicity to be apoptotic and necrotic 
simultaneously. Kellmann et al. [54] exposed human neuroblastoma cells 
(SH-SY5Y) to AZA1 and investigated protein expressions, identifying 
increased levels of Annexin AII as well as BAX, an apoptosis regulator. 
Available literature and results presented here point to apoptotic/necrotic 
processes being involved to some extent in, or as a result of, AZA toxicity.  
 
Conclusion 
Based on data obtained in the present study, AZAs are not genotoxic per se. 
Flow cytometer analysis showed a clear shift from early to late apoptosis in 
Jurkat T cells and HepG-2 cells; CaCo-2 cells did not show a clear apoptotic 
profile. In all cases however FITC+ / PI+ stained cells (late 
apoptosis/necrosis) agreed well with the percentage tail DNA detected in the 
COMET assay, suggesting this DNA fragmentation to be a result of 
apoptotic/necrotic processes rather than genotoxicity. Jurkat T cells were the 
most sensitive to AZAs exposure, followed by HepG-2 cells. CaCo-2 cells 
were the least sensitive in the study conducted here. While the overall effect 
on the cell lines seems to be similar for all three analogues, they differ in 
their potencies within one cell line. AZA3 shows the earliest and possibly 
strongest effect in Jurkat T cells, the data obtained do not allow for a clear 
differentiation between AZA1 and AZA2. AZA1 shows the lowest potency in 
HepG-2 cells, no clear difference in potency can be suggested for AZA2 and 
AZA3, or all three analogues in CaCo-2 cells. The different potencies of 
AZA1-3 and sensitivities of cell lines are in agreement with the literature 
available. Only limited data is available on the involvement of apoptosis in 
AZA toxicity, the present study contributing to the overall knowledge. 
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Chapter 5  
General Discussion 
Harmful algae blooms (HABs) are an increasing global problem [1-4]. The 
exact reasons for their increasing presence remain unknown but natural 
changes in the environment as well as human impact have been suggested 
[5-9]. Of the species involved in HABs only a small percentage are known to 
be potential toxin producers [1, 10]. They can release toxins either directly 
into the water or, serving as a food source for filter feeding shellfish, the 
larvae of some crustaceans and finfish, enter the food web where they can 
accumulate and/or bio-magnify throughout [1, 11, 12]. Filter feeding shellfish 
especially are highly tolerant of phycotoxins and can accumulate them up to 
levels where they can pose a risk to human consumers [1, 2, 13, 14]. It was 
estimated in the year 2000 that approximately 60,000 individuals suffered 
intoxication from phycotoxins worldwide [8]. The current legal level of 
phycotoxins permissible in shellfish meant for the market is controlled by EU 
Regulation (EC) No 853/2004 [15]. However, these regulations are mostly 
based on relatively limited acute toxicity data. Concern has been raised that 
this regulation might not be sufficient to protect all consumers, especially 
high shellfish consumers7 [15]. The EFSA Panel on Contaminants in the 
Food Chain concluded that insufficient evidence is available to establish a 
tolerable daily intake (TDI) for any of the phycotoxins. For this reason they 
proposed acute reference doses (ARfDs) [16, 17]. However, these ARfDs 
are also mostly based on acute toxicity studies on animals by i.p. injection 
which may not fully reflect the human route of oral intoxication [18]. Various 
in vivo and in vitro studies have been performed over the years aiming to 
increase knowledge about phycotoxins and improve the risk assessment and 
human protection, especially in relation to sub-acute or repeated exposures 
at sub-clinical doses. One aspect of safety assessments of biotoxins is the 
investigation of genotoxicity [19]. To date, no information on genotoxicity has 
                                                          
7 High consumers = shellfish consumers that eat portion sizes well above the EFSA calculated mean. 
Data are based on consumption surveys given by various European countries [16, 17].  
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been published for AZAs [16]. Several studies have investigated the 
genotoxic potential of OA. While OA has not tested positive in standard 
genotoxicity tests, such as the Ames test [20], it has tested positive in other 
assays. In brief, Aonume et al. [20] found OA to test positive in Chinese 
hamster lung cells (CHL) using diphtheria toxin resistance as a selective 
marker. A study by Tohda et al. [21] found sister-chromatid exchange, mitotic 
cells and chromosome/nuclei fragmentation in human lymphpoblastoid cells 
and Chinese hamster ovary cells. The authors concluded OA to be directly 
genotoxic [21]. This was supported by Fessard et al. [22] identifying 
chromosome condensation and DNA adduct formation in the absence of 
cytotoxicity. In contrast, other studies such as Le Hegerat et al. [23] 
concluded OA to be rather aneugenic. These studies detected premature 
sister chromatid separation, centromere-positive micronuclei and the loss of 
whole chromosomes [23-25]. Except for the study by Fessard et al. [22] no 
information on possible cytotoxicity or other DNA damaging processes have 
been included in these publications. DNA fragmentation is also one of the 
effects of cell death by either necrosis or apoptosis. Therefore, assays that 
investigate primary DNA damage will also detect DNA fragmentation which is 
due to cytotoxicity or apoptotic processes rather than genotoxicity [26-28]. In 
the absence of further data, this can lead to misclassification of the genotoxic 
potential of the test compound. The integrated evaluation of cell death 
mechanisms as part of genotoxic testing allows the determination of false 
positive results and for a more precise data interpretation [26, 29]. It has 
been suggested by the EFSA panel that some of the observations in in vivo 
and in vitro genotoxicity studies might reflect cytotoxicity rather than 
genotoxicity [17].  
The present study investigated the genotoxic potential of OA and AZA1-3. In 
contrast to the above mentioned studies, a more integrated approach was 
used in this investigation. In addition to determining DNA damage caused by 
the compounds, the effects on cytotoxicity, cell number and a marker for 
early apoptosis were included in the study design. Positive controls (Chapter 
2) were used to establish in house data for subsequent biotoxin studies and 
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to illustrate and support the integrated approach. The three positive controls 
used and their effects are described in greater detail in Chapter 2. In brief, 
EMS showed a direct genotoxic effect, in the absence of cytotoxicity and 
apoptosis. In contrast, CdCl2 a widely used positive control for genotoxic 
studies, tested positive not only for DNA damage but also for early and late 
apoptosis. Additionally, Staurosporine, a non-genotoxic apoptosis inducer 
also showed modest DNA fragmentation. Based on these preliminary 
studies, data interpretation for all phycotoxins was based on information 
obtained from all endpoints. OA and AZAs both showed an increase in DNA 
fragmentation at most time points, concentrations and cell lines investigated 
in the present study. These data by themselves would suggest a modest 
genotoxic potential of all four phycotoxins. The modest or strong cytotoxicity 
observed in the Trypan Blue Exclusion assay for the higher concentrations in 
Chapter 2, 3 and 4 confirms that the appropriate concentration range was 
used in these investigations [26, 30, 31]. In cases of a substantial reduction 
in cell viability, for example with CdCl2 but also AZAs in Jurkat T cells and 
HepG-2 cells, the DNA damage detected in the COMET assay coincides with 
the reduction in cell viability (Chapter 2 and 4). In other cases, such as 
exposure of all cell lines to the direct genotoxic agent EMS, or Jurkat T cells 
to OA, the DNA fragmentation occurs in the absence of overt cytotoxicity 
(Chapter 2 and 3). In general, these data suggest that at least part of the 
DNA fragmentation detected might be due to other processes than direct 
genotoxicity. Another criterion for the considered interpretation of findings in 
genotoxicity assays, which is not frequently included in study designs, is the 
effect of the test compounds on cell number. If direct genotoxic damage 
occurs, the cell number should stay substantially constant within the non-
cytotoxic concentration range [32]. In this study, all compounds, except 
Staurosporine, induced a significant reduction in cell number in at least two 
of the cell lines and one time point (Chapter 2, 3 and 4). It stands to reason 
that cytotoxic and/or apoptotic processes have taken place rather than direct 
DNA damage. Cells that have possibly undergone apoptotic or necrotic 
processes might have been severely damaged and lost within the incubation 
period and would therefore not be detected by the Trypan Blue Exclusion 
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assay after the full incubation period. This is most likely an explanation for 
the reduction in cell number found within the current study, especially after 
the longer incubation time (Chapter 2, 3 and 4). The possibility that apoptotic 
processes are responsible for the reduction in cell number, but also the DNA 
damage detected in the present study, was supported by the findings from 
the flow cytometrical analysis (Chapter 2, 3 and 4), with the exception of 
EMS. CdCl2, OA and AZAs caused early and late apoptosis in the vast 
majority of cell lines. Overall, no substantial amount of early or late apoptosis 
could be seen for EMS. The reduction in cell number for EMS is far more 
modest than for any other compound and all other endpoints (cell viability, 
DNA fragmentation, flow cytometer analysis) confirming EMS as a direct 
genotoxic compound. For CdCl2 and all phycotoxins investigated, the 
percentage of late apoptotic cells generally agreed well with the detected 
cytotoxicity, reduction in cell number and increase in DNA fragmentation. As 
DNA fragmentation is a late apoptotic event [28, 33] all data in the present 
study indicate a major involvement of apoptotic processes in the DNA 
fragmentation observed, rather than direct genotoxicity. The COMET assay 
workgroup within the 4th International Workshop on Genotoxicity Testing [26] 
came to the consensus that cytotoxicity data should be included in the 
interpretation of results from COMET analysis. The findings in the present 
study strongly support this recommendation. Data obtained also stress the 
need to include other endpoints, such as cell number and markers for 
apoptosis in genotoxic studies. If the COMET data from the current study 
were assessed on their own, one might have concluded that OA and AZA1-3 
are moderately genotoxic (Chapter 3 and 4). However, taking the additional 
data into account, including observations made with the positive controls 
(Chapter 2), allowed for a more considered evaluation. The study design 
used in this investigation provides a certainty that the right concentration 
range was applied. Furthermore, cell viability data and cell numbers point 
towards other processes involved in the detected DNA fragmentation which 
is also supported by flow cytometer analysis. All aspects together allow for 
the conclusion that cytotoxicity and apoptosis contribute substantially to the 
DNA damage detected in the COMET assay. 
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The time course of biochemical events following compound exposure 
depends on a variety of factors, such as the compound itself, the cell line, 
exposure time/concentration and the endpoint investigated [34]. For all 
endpoints included in the present study, the exposure time, with the 
exception of OA in HepG-2 cells (Chapter 3), and exposure concentration 
have been kept constant, leaving the compounds and cell lines as possible 
factors for differences detected. In the current study, Jurkat T cells, CaCo-2 
cells and HepG-2 cells showed different sensitivities to the phycotoxins 
investigated. For OA (Chapter 3) the order of sensitivity of the cell lines is, in 
increasing order, CaCo-2 cells < Jurkat T cells < HepG-2 cells whereas for 
AZAs (Chapter 4) the order of sensitivity is, in increasing order, CaCo-2 cells 
< HepG-2 cells < Jurkat T cells. The cell line sensitivity seems to be the 
same for all three AZAs tested. This is in agreement with the limited literature 
available and has been discussed in greater detail in Chapter 4. The EFSA 
report [16] gives TEFs for AZAs with potencies relative to AZA1 as follows, 
AZA2 (1.8) › AZA3 (1.4) › AZA1 (1). Data in the present study do not indicate 
such clear differences between the three analogues tested. AZA3 for 
example, seems to be the most potent in Jurkat T cells, while no clear 
difference can be seen between AZA1 and AZA2. In HepG-2 cells AZA2 and 
AZA3 are more potent than AZA1; however, no clear distinction between 
AZA2 and AZA3 can be made. As described in Chapter 4 in more detail, 
comparison with the literature is difficult. Data available are often limited to a 
single endpoint [35] and matching endpoints are often detected by different 
methods (in vivo vs in vitro) [16]. 
In contrast to AZAs, the reduction in cell number after initial experiments for 
HepG-2 cells exposed to OA was substantial. As previously mentioned in 
Chapter 3, the exposure time therefore had to be reduced to 12 hours and 24 
hours. To allow direct comparison of OA and AZAs here, final concentrations 
of OA have been converted from ng/mL to nM, giving values of 4 nM (3 
ng/mL), 12 nM (10 ng/mL), 41 nM (33 ng/mL) and 124 nM (100 ng/mL). The 
final concentrations of AZA1-3 used in the present study were 0.001, 0.01, 1 
and 10 nM. When comparing, for example OA at 12.4 nM and AZAs at 10 
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nM in HepG-2 cells at 24 hours, the cell number for OA is already 
substantially lower than for AZAs (Table 3.5. and 4.5.). This indicates a 
higher potency of OA compared to AZAs in HepG-2 cells. Limited data are 
available on the comparison between OA and AZAs in the literature. 
Sérandour et al. [36] used the MTT assay to determine the cytotoxic effect of 
OA and AZA1 on various cell lines, including CaCo-2 cells and HepG-2 cells. 
Exposure concentrations ranged from 0.001 to 1000 nM at an exposure time 
of 48 hours. The authors concluded that OA has a significant effect on CaCo-
2 cells, but no substantial effects were observed with AZA1. The cell 
viabilities for OA at 48 hours are slightly lower in the current study compared 
to the percentages given by Sérandour et al. [36]. However, there is an 
overall agreement, amongst the findings, of a significant effect of OA on 
CaCo-2 cells. In contrast, a significant effect of AZA1, after 48 hours of 
exposure, could be detected on the cell viability of CaCo-2 cells in the 
present study. Sérandour et al. [36] found HepG-2 cells to be more sensitive 
to AZA1 than OA [36]. Direct comparison of cytotoxicity data is only possible 
with data of AZA1. Data obtained in the present study are in agreement with 
data obtained by Sérandour et al. [36]. Direct comparison of OA data is not 
possible due to the different time points. A study by Roman et al. [37] 
investigated the changes in the F-actin pool after exposure of neuroblastoma 
cells to AZA1 at concentrations of 1 to 10,000 nM for 24 hours (IC50 after 24 
hours = 7.5 µM) and OA (at IC50 values, data not published). The authors 
concluded a lower toxicity for AZA1. Although based on different endpoints, 
data from the present study are in line with the findings by Roman et al. [37]. 
The data by Roman et al. [37] are furthermore supported by other studies, 
showing AZA1 to require higher concentrations than OA to cause 
morphological/cytoskeletal alterations in various cell lines [38, 39]. In the 
current study, effects on all endpoints can already be shown after 24 hours 
for OA in all cell lines. Most effects for AZAs are only detectable after 48 
hours of exposure. The data obtained in the present study therefore suggest 
OA to be more potent and faster acting than AZAs.  
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As can be seen here as well as in previous chapters, the information 
available on genotoxicity is limited and in parts contradicting. Information on 
reproductive and developmental effects is scarce and no chronic 
exposure/carcinogenicity studies on AZAs have been performed using 
standard tests. The current regulations in place appear to minimize the risk 
of acute intoxications of humans by contaminated shellfish [18]. However, 
based on the toxicity data currently available, the EFSA panel concluded that 
the regulatory limits might not be adequate to fully protect human shellfish 
consumers from potential long term effects. In view of this, considerations 
should be given to repeated-dose feeding studies to establish effects of 
prolonged exposure and robust TDIs [15, 18]. To protect high consumers 
from acute effects, the EFSA panel proposed 400 g of shellfish meat to be 
used in risk assessment as a realistic estimate of a large portion [15]. 
Consumption data are limited and the information available is based on data 
submitted by various European countries on request from EFSA. These data 
are based on national food consumption surveys and do not necessarily 
differentiate between portion size for fish and other seafood and 
cooked/uncooked shellfish. The EFSA panel in turn used these data to set 
more conservative, but not unrealistic estimates, of dietary exposure to 
phycotoxins in the EU. They recommended expanding the database on 
portion size and frequency of consumption to help with safety assessment 
[15]. Various aspects of hazard identification are currently missing, such as 
the previously mentioned genotoxicity, carcinogenicity and long term toxicity 
data. However, future work should also be considered on the 
absorption/distribution and metabolism in animals and humans. A study by 
Aune et al. [40] was unable to identify any synergistic or additive effect when 
administrating OA and AZA1 together to mice. The oral LD10 and LD50 were 
established for both OA and AZA1 by the authors. The doses were then used 
for the exposure to the toxins at following combinations, OA at LD10 and 
AZA1 at LD10, OA at LD50 and AZA1 at LD10. Mice were sacrificed after 24-30 
hours [40]. Although the time course of effects for OA and AZA appears to be 
similar in in vivo studies, the data given in the present study (Chapters 3 and 
4) suggested a later onset of effects for AZA1 compared to OA. While effects 
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could be seen for OA at 24 hours, most effects of AZAs only became 
detectable at 48 hours. Therefore, the exposure time investigated by Aune et 
al. [40] might possibly have been too short to fully identify synergistic/additive 
effects. In general, attention should focus on the fact that shellfish often 
contain more than one class of phycotoxins. Further information on 
combined effects/interactions is needed to fully assess potential risks [15, 
18]. 
In the present study, the genotoxic effect of OA and AZAs were investigated 
in vitro and results might assist in the evaluation of these compounds in view 
of future risk assessment. Based on data obtained in the current study and in 
the literature cited here and in previous chapters, OA does not appear to be 
overtly genotoxic. However, it has been identified as a tumour promoter, as 
described in more detail in Chapter 1 and Chapter 3 [17, 41-44]. Data on 
AZAs obtained in the present study also do not indicate overt genotoxicity. 
Differently to genotoxic compounds, tumour promoters require repeated 
exposure above a certain threshold to cause an effect. Physical wounding, 
irritating chemicals and cytotoxic drugs, for example, have been identified as 
tumour promoters resulting in cell proliferation, altered gene expression as 
well as inflammation and changes in cell adhesion and cell-cell 
communications [30]. The available literature has identified occasional 
tumours after AZAs exposure in vivo [45] as well as cytotoxicity and loss of 
cell-surface and cell-cell interactions [39, 46, 47]. Some of these effects 
could also be seen in the present study. While no definite answer can be 
given at this point, data suggest the possibility that AZAs might have the 
potential to act as tumour promoters.  
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Conclusions 
The main goal of hazard identification is the realistic assessment of the 
potential risks a compound might have. In the case of OA and AZAs most 
information is based on acute toxicity. The limited data available on chronic 
exposure, carcinogenicity or genotoxicity are often contradicting. This 
present study used the COMET assay to investigate the genotoxic potential 
of OA and AZAs. In contrast to most other studies, various endpoints such as 
cytotoxicity, cell number and possible involvement of apoptosis were 
included in the data interpretation. The data obtained indicate that OA and 
AZAs are not genotoxic per se. Apoptotic processes make a major 
contribution to the observed DNA fragmentation. Genotoxic testing is a key 
component of risk assessment to determine whether a compound can a) 
cause heritable damage, b) predict genotoxic carcinogenicity if data on 
carcinogenicity are not available and c) contribute to the knowledge of the 
mechanisms of action [18, 48]. The data obtained in this study indicates that 
the risk of genotoxic damage after consumption of shellfish meat containing 
OA or AZA1-3 is marginal. This suggests no immediate need for more 
severe regulatory limits, especially for repeated/regular consumption of 
phycotoxin contaminated food at concentrations below the regulatory limits 
and/or concentration without acute clinical effects. The information obtained 
in this study contributes to the overall knowledge of OA and AZAs toxicity. 
However, further work is necessary to fully assess the potential risk these 
compounds might have. The lack of a DNA damaging effect but clear 
contribution of apoptosis to AZAs toxicity might assist in future research on 
the mechanism of action, which is still unknown. As previously mentioned, 
shellfish samples often contain more than one toxin group. Hence, 
information on possible interactions and/or synergistic effects is required. 
Further research should also include in vivo exposure to clinical and sub-
clinical levels of phycotoxins, as possible metabolic and/or elimination 
processes might not be reflected in vitro.  Much progress has been made but 
further information is still required to fully assess the potential risk of 
phycotoxins to human shellfish consumers. 
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